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ABSTRACT 
Fibroblast growth factors (FGFs) are secreted signaling proteins that are 
highly conserved from nematodes to humans. They are essential both for 
embryonic development as well as for various biological and pathological 
processes during adulthood. Drosophila FGF Branchless (Bnl) demonstrates high 
similarity to mammalian FGFs and is involved in the development of fly tracheal 
system. However, Bnl contains extended N- and C-terminal domains with 
unknown function, which make the protein approximately 3 times longer than 
mammalian FGF homologues.  
This thesis reports about proteolytic processing of the Bnl protein that 
removes its N- and C-terminal regions and liberates the central FGF domain. 
According to the obtained results, this cleavage is required for Bnl activation 
and is essential for correct development of embryonic tracheal system. 
Drosophila Furin1 protease was identified as an enzyme responsible for Bnl 
processing. Four conserved furin recognition motives were found in the Bnl 
protein, however, only three of them contribute to Bnl cleavage in Drosophila 
cell culture. Interestingly, a similar furin recognition motif was identified in 
FGF10, the vertebrate homologue of Bnl. Moreover, this motif is conserved in 
vertebrate FGF10 homologues and is processed by a Furin-related protease in 
Drosophila cell culture. 
Taking together, the results of this study suggest a novel furin-mediated 
mechanism of post-translational regulation of FGF activity during tracheal 
development in Drosophila. Moreover, the obtained data raise the possibility 
that the observed regulatory mechanism is evolutionary conserved and the 
biological function of vertebrate homologues of Bnl is modulated in a similar 
fashion. 
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1 INTRODUCTION 
Embryonic development is a complex process that involves formation, growth, 
specification and shaping of various tissues and organs of a body. It relies on 
numerous cell to cell signaling events, which orchestrate and coordinate the whole 
morphogenetic process according to a certain developmental program. Therefore, 
precise temporal and spatial regulation of expression and function of signaling proteins 
is essential for proper embryonic development (Gilbert, 2006). This regulation occurs 
at several levels including modulation of gene expression as well as post-translational 
proteolytic processing of already synthesized signaling molecules. Such protelytic 
maturation is performed by members of the subtilisin-like proprotein convertase (SPC) 
family of endoproteases. These enzymes are responsible for proteolytic modification of 
different proteins in eukaryotes, including peptide hormones and growth factors 
(Steiner, 1998). Fibroblast growth factors (FGFs) are highly conserved signaling 
molecules, implicated in various aspects of embryonic development in vertebrates and 
invertebrates, including mesoderm induction, formation of organs and branching 
morphogenesis (Böttcher and Niehrs, 2005; Kadam et al., 2009). However, post-
translational regulation of their biological activity is poorly studied. The present thesis 
provides the information about post-translational proteolytic activation of Drosophila 
FGF homologue Branchless (Bnl), which is performed by a subtilisin-like proprotein 
convertase and is essential for Bnl function during development of embryonic tracheal 
system. 
 
1.1 Proteolytic processing of proteins in eukaryotic cells 
Many eukaryotic proteins are synthesized in cells as large precursor 
molecules that are subsequently subjected to limited proteolysis. Intracellular 
protein processing represents a specific regulatory mechanism that serves various 
biological purposes (reviewed in Turk, 2006). 
Proteins that possess an amino-terminal (N-terminal) signal sequence are 
co-translationally transferred into the lumen of the endoplasmic reticulum (ER). 
This translocation is regulated by proteolytic cleavage of the signal sequence by a 
specific enzyme called signal peptide peptidase (SPP). Therefore, proteolytic 
processing is essential for the liberation of the newly produced polypeptide into 
the ER lumen and eventually for its direction to the destination place (Martoglio 
and Dobberstein, 1998; Emanuelsson et al., 2007; Alberts et al., 2002). 
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 Futhermore, proteolytic processing also serves as a mechanism of 
regulation of intercellular communication, since many prohormones, 
neuropeptides, extracellular receptors and growth factors require post-
translational proteolytic activation (Rockwell et al., 2002; Holyoak et al., 2004). 
The proteolysis preferentially occurs at specific amino acid residues (protease 
recognition sites) and represents a protein modification step rather than its 
degradation into separate amino acids. Such proteolytic precursor modification is 
very common among eukaryotes and frequently occurs at repetitive basic amino 
acid residues (Steiner, 1998; Rockwell et al., 2002). 
 
1.1.1 Subtilisin-like proprotein convertases (SPCs) 
 The specialized family of calcium-dependent serine proteases called 
subtilisin-like proprotein convertases is known to be responsible for the 
proteolytic activation of many secreted proproteins. The first member of this 
group, Kex2 protease (kexin, E.C. 3.4.21.61), was identified in Saccharomyces 
cerevisiae. This enzyme was implicated in proteolytic maturation of an α-mating factor 
in MATα haploid yeast cells (Leibowitz and Wickner, 1976; Achstetter and Wolf, 1985). 
 There are several kexin homologues identified in mammalian cells. They 
include furin, prohormone convertase (PC) 1/3, PC2, PC4, PC5/6, PC7 and PACE4. 
These proteins contain a conserved catalytic domain, also present in Kex2, and an 
additional Homo B domain (or P domain) required for their proteolytic activity. Some 
of the SPC family members also carry cystein-rich and serine/threonine-rich domains 
of unknown function (Figure 1). Moreover, all these enzymes are initially synthesized 
as zymogens and undergo subsequent autoproteolytic activation (Rockwell et al., 
2002; Thomas, 2002). 
 
 
 
 
 
 
Figure 1: Comparison of subtilisine-like proprotein convertases (adapted from 
Thomas, 2002). Schematic representation of furin, PC2 and kexin. The active site residues are 
in red. The oxyanion-hole amino acids are marked in green. 
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Mammalian SPCs are subdivided into two classes by the presence or absence of 
a transmembrane domain. PC1/3, PC2 and PC4 do not carry the transmembrane 
domain, they are expressed in a tissue-specific manner and localize to the regulated 
secretory pathway (Rockwell et al., 2002). These enzymes are sorted into specific 
cellular compartments such as secretory granules that are enriched with protein 
precursors for several hours. Conversely, Kex2, Furin, PC7 and PACE4 are ubiquitously 
expressed transmembrane proteins that localize to the constitutive secretory pathway 
where they cycle between several cellular compartments (Mains et al., 1997; Rockwell 
et al., 2002). These proteases are transiently exposed to specific targets in the 
presence of a large amount of non-substrate proteins. Thus, the two subgroups of 
SPCs demonstrate different expression profiles, time of action and specificity towards 
protein precursors (Rockwell et al., 2002).  
 Members of the SPC family as well as the non specific digestive enzymes utilize 
the same mechanism of peptide bond cleavage characteristic for serine proteases. 
They catalyze the reaction of acyl transfer mediated by a group of catalytic amino 
acids (serine, histidine and aspartate) in the reactive center of the molecule (Perona 
and Craik, 1995; Holyoak et al., 2004). However, subtilisin-like proteases possess an 
additional catalytic residue called oxyanion hole Asn that also contributes to their 
proteolytic activity. (Holyoak et al., 2004; Rockwell et al., 2002) (Figure 1). 
 Proprotein convertases preferentially recognize and cleave their target 
proteins C-terminally at dibasic residues –K–R↓– or –R–R↓– (arrow shows the 
cleavage site; K – Lys; R – Arg). However, upstream basic amino acids may also 
contribute to the consensus recognition (Rockwell et al., 2002). 
 
1.1.2 Furin 
Human furin, which encodes a Kex2 homolog (Bresnahan et al., 1990), is the 
best studied member of the mammalian SPC family. It was shown to be involved in 
the processing of diverse protein precursors including growth factors, neuropeptides, 
extracellular matrix components and other proteases (Molloy et al., 1994; reviewed in 
Thomas, 2002). Human furin is a relatively big (794 amino acids) single-span 
transmembrane protein, whose homologues are ubiquitously expressed among 
vertebrate species. The protein carries a N-terminal signal peptide that directs the 
protease precursor to the ER lumen. Like other member of the SPC family, furin 
possesses the amino-terminal pro-peptide, which is removed in two steps by 
autocatalytic processing. This event was reported to be essential for furin folding, 
translocation and activation of its proteolytic activity (Anderson et al., 1997). The 
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catalytic domain of furin shows homology to subtilisin-like domains of the other 
proprotein convertases and contains the conserved Asp, His and Ser residues that 
constitute the catalytic triad found in all serine proteases (Thomas, 2002; Holyoak et 
al., 2004). In addition, furin contains a specific P-domain identified in subtilisin-like 
proprotein convertases but absent in bacterial subtilisin. The precise function of this 
domain remains elusive, however, it was proposed to be essential for modulation of 
pH and calcium requirements of the protease (Zhou et al., 1999; Thomas et al., 
2002). 
In contrast to the kexin protease, which cleaves proproteins at dibasic residues, 
the consensus motif recognized by furin is –R–X–K/R–R↓– (where X is any amino acid 
and the arrow identifies the cleavage position) and requires additional basic amino 
acid residues upstream of the cleavage point. Additionally, furin proteases effectively 
process a so-called minimal furin site, which includes two arginines separated by any 
two amino acids (–R–X–X–R↓–) (Krysan et al., 1999; Thomas, 2002; Rockwell et al., 
2002). 
The localization of furin protease within the cell is very dynamic and is described 
as a rapid cycling between trans-Golgi network (TGN), endosomic compartments and 
the cellular surface (Molloy et al., 1994; Molloy et al., 1999) (Figure 2).  
 
 
 
 
 
 
 
 
 
 
Figure 2: Furin subcellular localization. Furin (shown in blue) dynamically cycles between 
several cellular compartments. In TGN it cleaves different signaling propeptides and 
proreceptors. Cell-surface furin was shown to process the anthrax toxin. In early endosomes 
furin activates bacterial toxins, including diphtheria toxin and Pseudomonas exotoxin A. 
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Such complex enzyme trafficking contributes to the diversity of the intra- and 
extracellular substrates processed by furin and completely depends on the cytoplasmic 
domain of furin (Anderson et al., 1997; Molloy et al., 1999). The mechanism of furin 
intracellular trafficking is not completely understood. However, previous studies 
supposed that furin anterograde and retrograde transport is clathrin-mediated 
(Teuchert et al., 1999; Crump et al., 2001). Moreover, cell-surface furin can be 
internalized by endocytosis, which requires a specific interaction of the cytoplasmic tail 
of the enzyme with adaptor proteins (Liu et al., 1997). 
Furin plays an essential role in cellular communication during embryogenesis, 
homeostasis maintenance and disease. It was shown to regulate neuronal survival by 
proteolytic activation of pro-β-nerve growth factor (pro-β-NGF) (Lee et al., 2001b). 
Also, furin activity is required for Notch and Transforming growth factor-β (TGF-β) 
signaling (Bush et al., 2001; Cui et al., 2001). Furthermore, furin participates in 
proteolytic modification of the β-amyloid precursor protein (APP), thus being involved 
in the pathogenesis of Alzheimer’s disease (Walter et al., 2001; Isacson et al., 2002). 
Furin proteolytic activity was implicated in tumor metastasis and its expression is 
upregulated in many cancers (Bassi et al., 2001; Mbikay et al., 1997). Moreover, cell-
surface furin is able to activate bacterial toxins (Molloy et al., 1992; Klimpel et al., 
1992) and cause maturation of viral particles (including avian influenza virus, HIV-1 
and measles virus) (Molloy et al., 1999; Thomas, 2002) (Figure 2). 
Thus, furin represents a specific proprotein convertase with highly dynamic 
intracellular trafficking, whose proteolytic activity is involved in various biological and 
pathological aspects of cellular life and intercellular communication. 
 
1.1.3 Drosophila SPCs 
Three members of the SPC family were identified in Drosophila: Dfurin1 (Dfur1), 
Dfurin2 (Dfur2) and Amontillado (Amon). Dfur1 and Dfur2 proteases were 
characterized in vitro and demonstrate a close relation to mammalian furin (Roebroeck 
et al., 1991; Roebroeck et al., 1992; Roebroeck et al., 1993), whereas Amon shows 
homology with PC2 convertase (Siekhaus and Fuller, 1999).  
As their mammalian homologues, both Drosophila furins are transmembrane 
proteins that carry a N-terminal signal sequence and are preferentially localized in the 
late Golgi. The enzymes contain a subtilisin-like catalytic domain and a prodomain that 
is removed during protease maturation by autocatalytic cleavage (De Bie et al., 1995). 
Unlike human furin that has only one known isoform, Dfur1 exists in several different 
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isoforms (dfurin1, dfurin1-CRR and dfurin1-X) that differ in their subcellular 
localization (Roebroeck et al., 1993; Molloy et al., 1994; De Bie et al., 1995) (Figure 
3). 
Drosophila furins show similar proteolytic activity in vitro, however, they 
demonstrate non-overlapping zygotic expression during embryogenesis (Roebroeck et 
al., 1993; De Bie et al., 1995). Both Dfur1 and Dfur2 transcripts are maternally 
supplied and demonstrate ubiquitous localization in early embryos. Later in 
development Dfur1 expression can be detected in various organs including the central 
nervous system (CNS), hindgut and lateral clusters of epithelial cells (Hayflick et al., 
1992; Roebroeck et al., 1993; De Bie et al., 1995). Dfur2 transcripts are revealed in 
the embryonic nervous system and in the developing trachea at late embryonic stages 
(Roebroeck et al., 1995). 
 
 
 
 
 
 
 
Figure 3: Drosophila furins (adapted from De Bie et al., 1995). Schematic drawing of the 
alternatively spliced Drosophila Furin1 isoforms (Dfurin1, Dfurin1-CRR and Dfurin1-X), 
Drosophila Furin2 (Dfurin2) and human furin (hFurin). The active site residues are in red. The 
oxyanion-hole amino acids are marked in green. 
 
Drosophila Amon is a PC2 homolog and was implicated in the development of the 
embryonic nervous system. Embryos deficient for the amon gene demonstrate partial 
embryonic lethality and have an impaired hatching behavior and larval growth, 
however, no morphological defects can be observed in these mutants (Siekhaus and 
Fuller, 1999; Rayburn et al., 2003). 
Although substrates for Drosophila SPCs were unknown for some time, it was 
recently shown that a fly homolog of TGF-β, Decapentaplegic (Dpp), undergoes 
multistep proteolytic maturation catalyzed by both Drosophila furins (Künnapuu et al., 
2009). Moreover, Dfur1 and Dfur2 demonstrate differential specificity towards the 
three Dpp cleavage sites that represents a mechanism of ligand activity modulation 
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(Künnapuu et al., 2009). In contrast to the conservation of furin function for 
TGFβ/Dpp processing, furin-mediated cleavage is not essential for Drosophila Notch 
pathway, since the major pool of fly Notch can be detected as a full-length protein 
(Kidd and Lieber, 2002). Moreover, Drosophila adipokinetic hormone (AKH), the fly 
analog of glucagon, represents a substrate for Amon (Rhea et al., 2010). 
In present work, one of the Drosophila fibroblast growth factors Branchless (Bnl) 
is identified as a novel target for the Dfur1 protease and this processing is essential 
for Bnl biological function. 
 
1.2 Fibroblast growth factors 
Fibroblast growth factors (FGFs) constitute a large family of highly 
conserved signaling molecules found in eukaryotes from nematodes to humans. 
These factors are involved in a broad spectrum of biological processes in living 
organisms, including angiogenesis, wound healing, limb formation, branching 
morphogenesis of epithelial tubes and cancerogenesis (reviewed in Ornitz and 
Itoh, 2001; Affolter and Caussinus, 2008; Korc and Friesel, 2009). Despite the 
given name, these cytokines regulate not only fibroblast proliferation, but also 
known as potential mitogens for endothelial cells, smooth muscle cells, 
chondrocytes and other cell types. Moreover, these factors are required for 
cellular differentiation, survival and migration (Ornitz and Itoh, 2001).  
 
1.2.1 Members of vertebrate FGF family of proteins 
Mammalian FGF family consists of 23 members identified up to date. The 
first member of this family – basic fibroblast growth factor (FGF2) was identified 
in 1975 as a potent inducer of cell proliferation from bovine pituitary gland 
(Gospodarowicz, 1975; Ribatti et al., 2007). FGF3-FGF9 were discovered in 
mammalian cell culture or identified as oncogenes (Coulier et al., 1991; Tanaka 
et al., 1992; Itoh and Ornitz, 2008). Other FGFs were identified on the basis of 
their sequence homology (Ribatti et al., 2007). 
Vertebrate FGFs are relatively small proteins whose molecular mass varies 
from 17 to 34 kDa. The FGF core domain contains 28 highly conserved and six 
identical amino acids (Ornitz, 2000; Plotnikov et al., 2000). Moreover, structural 
analysis of FGF1 and FGF2 revealed a specific FGF domain structure, containing 
12 antiparallel β strands, which was shown to be critical for FGF receptor binding 
(Figure 4) (Eriksson et al., 1990; Zhu et al., 1990). 
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Most FGF family members contain classical N-terminal signal sequence and 
are effectively secreted from the producing cells. However, some vertebrate FGFs 
(FGF1, FGF2, FGF9, FGF16 and FGF20) possess no signal peptide, but are 
nevertheless found in the extracellular space. Among those, FGF1 and FGF2 are 
released from cells upon cellular damage. Also, a special exocytic secretory 
mechanism was proposed for these FGFs. Other FGF proteins lacking classical N-
terminal signal peptides contain an internal hydrophobic sequence, which was 
demonstrated to be responsible for their secretion (Mignatti et al., 1992; Ornitz 
and Itoh, 2001; Itoh and Ornitz, 2004). 
 
 
 
 
 
Figure 4: FGF protein structure. (A) Schematic representation of a typical FGF protein 
(adapted from Ornitz and Itoh, 2001). The N-terminal signal peptide is shown in grey. The 
heparin-binding domain is in red. (B) 3D structure of the human FGF1 as a prototypic FGF 
ligand (from Protein Data Bank online resource). 
 
Fibroblast growth factors as well as many other extracellular signaling 
peptides carry varying degrees of N- and O-linked glycosylation. FGF3, FGF4, 
FGF9, FGF16, FGF17 and FGF18 contain a single N-glycosylation motif, which is 
required for their secretion from the cells (Kiefer et al., 1993; Miyakawa and 
Imamura, 2003). Moreover, N-linked glycosylation was also implicated in FGF4 
stability, since the unglycosylated protein undergoes proteolytic cleavage outside 
the cell (Bellosta et al., 1993). FGF5, FGF6, FGF7 and FGF10 demonstrate both N- 
and O-glycosylation (Bates et al., 1991; Asada et al., 1999; Hsu et al., 1998; 
Park et al., 1998), whereas FGF23 carries only an O-linked sugar modification, 
which is required for its secretion (Fukumoto, 2005; Bergwitz et al., 2009). 
Members of the FGF family were also shown to interact with heparin and 
heparan sulfate proteoglycans (HSPGs). This is a group of glycoproteins found on 
the cell surface or in the extracellular matrix (ECM). These proteins carry linear 
heparin sulfate glycosaminoglycan (HSGAG) sugar chains attached to specific 
amino acid residues. HSPGs were implicated in a number of signal transduction 
pathways, including FGF signaling (Häcker et al., 2005; Dreyfuss et al., 2009; 
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Gutierrez et al., 2010). Moreover, structural studies have identified HSPGs as 
essential components of the FGF-FGFR signaling complex and shown that a highly 
variable tissue-specific modification pattern of linked glycosaminoglycans 
modulates the specificity of receptor-ligand interaction (Ornitz, 2000; Pellegrini, 
2001; Sugaya et al., 2008). 
 
1.2.2 Drosophila FGFs: Pyramus and Thisbe 
Drosophila melanogaster possesses three genes encoding FGF homologues: 
thisbe (ths, also known as fgf8-like1), pyramus (pyr, fgf8-like2) and branchless 
(bnl) (Sutherland et al., 1996; Gryzik and Müller, 2004; Stathopoulos et al., 
2004). Ths and Pyr contain 748 and 766 amino acid residues and show high 
homology to human FGF8 (32-35% amino acid identity in the FGF core domain) 
(Gryzik and Müller, 2004; Stathopoulos et al., 2004). Both proteins carry N-
teminal signal peptides and are secreted from the cells (Stathopoulos et al., 
2004; Gryzik and Müller, 2004). Interestingly, neither Pyr nor Ths possess a 
heparin binding domain found in other FGF proteins and probably do not interact 
with extracellular HSPGs or this interaction is not specific (Stathopoulos et al., 
2004). 
The expression of both FGFs is identical at the early stages of Drosophila 
embryogenesis and is localized in the lateral neurogenic ectoderm, suggesting the 
redundancy of their biological function. However, later in development the 
expression pattern of Pyr and Ths becomes distinct from each other and can be 
revealed in different subsets of the embryonic neuroectoderm (Gryzik and Müller, 
2004; Stathopoulos et al., 2004). Moreover, investigation of Drosophila embryos 
lacking pyr and/or ths expression suggests that the ligands have overlapping as 
well as individual biological functions during embryonic development 
(Introduction 1.4.1; Kadam et al., 2009; Klingseisen et al., 2009).  
 
1.2.3 Drosophila FGFs: Bnl 
Drosophila FGF Bnl is a 770 amino acid protein, with a molecular mass of 84 
kDa (Sutherland et al., 1996) (Figure 5). Among vertebrate FGFs Bnl shows the 
highest homology to FGF10, which is essential for vertebrate lung development 
(Min et al., 1999). Bnl carries a N-terminal signaling sequence and is secreted 
(Sutherland et al., 1996). Moreover, similar to other members of the FGF family, 
the Bnl ligand possesses the heparin binding domain that enables its interaction 
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with extracellular HSPGs. Despite the high similarity to known FGFs, Bnl (as well 
as the other Drosophila FGFs Pyr and Ths) is unusually large compared to 
vertebrate FGFs, whose maximal molecular weight does not exceed 37 kDa 
(Ornitz and Itoh, 2001; Sutherland et al., 1996). The conserved FGF domain of 
Bnl is flanked by the extensive N- and C-terminal regions that are not present in 
vertebrate homologues (Figure 5). These regions demonstrate no similarity to any 
known proteins and contain repetitive stretches of Ser or Gln residues of 
unknown purpose (Sutherland et al., 1996). 
 
 
 
 
Figure 5: Drosophila Bnl protein and its relation to human FGFs. (A) Schematic 
representation of the Bnl protein compared to human FGFs (adapted from Sutherland et 
al., 1996). The N-terminal signal peptides are marked in black, the FGF homology 
domains are shown in yellow. Numbers show percent of homology in the core domain. (B) 
Relation of Bnl to the human FGF members based on their amino acid homology. 
 
Bnl demonstrates a highly dynamic expression pattern during Drosophila 
embryonic development. Its expression starts at stage 5 of fly embryogenesis 
around the cephalic furrow and at the posterior transversal furrow. At stage 11, 
Bnl can be detected in multiple epidermal clusters near invaginating tracheal cells 
and continues later at the places of subsequent migration of the growing tracheal 
branches. During later stages, Bnl epidermal expression fades and the protein is 
detected in the embryonic gut (Sutherland et al., 1996). Bnl is the only ligand for 
the receptor tyrosine kinase Breathless (Btl) (Sutherland et al., 1996) and their 
interaction was shown to be essential for tracheal development in Drosophila 
(Klämbt et al., 1992; Reichman-Fried et al., 1994). 
 
1.3 FGF signaling 
 FGF signaling is initiated by specific interaction of the extracellular FGF 
ligand with the cell-surface FGF receptor (FGFR). This interaction leads to the 
receptor activation and induces specific intracellular signaling cascade, depending 
on FGF-FGFR combination and cell context (Eswarakumar et al., 2005). FGF 
signaling may result in various cellular responses including expression of target 
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genes, rearrangement of actin cytoskeleton, cell proliferation and survival (Ornitz 
and Itoh, 2001). 
 
1.3.1 FGF signaling in vertebrates 
 There are four Fgfr genes (Fgfr1-4) described in humans and mice. They 
encode receptor tyrosine kinase (RTK), transmembrane proteins that carry an 
extracellular domain containing three immunoglobulin-like (Ig-like) domains, one 
of which is responsible for ligand binding. An intracellular portion of these 
receptors contains a tyrosine kinase domain, which enables protein 
phosphorylation (Mohammadi et al., 2005). 
The knowledge about the mechanism of FGF signaling is based on studies of 
mammalian FGFR1 and other vertebrate RTKs. Extracellular FGF-FGFR interaction 
results in conformational changes in two neighboring FGFR molecules and 
promotes their dimerization. This dimerization enables intracellular tyrosine-
kinase domains to cross-phosphorylate each other at different tyrosine residues. 
This phosphorylation activates downstream signal transduction (Mohammadi et 
al., 2005). The activated FGF receptor induces phosphorylation and recruitment 
of various docking and adaptor molecules and protein kinases, hence propagating 
the signal and transforming the extracellular stimuli into the intracellular 
signaling cascade (Turner and Grose, 2010) (Figure 6). Phosphorylated tyrosine 
residues of FGFR serve as binding sites for the adaptor protein FRS2 (Fibroblast 
growth factor receptor substrate 2) (Lin et al., 1998). 
 
 
 
 
 
 
 
Figure 6: FGF signaling pathway (adapted from Turner and Grose, 2010). 
Schematic representation of the signaling network mediated by activated FGFR with the 
four basic pathways: Ras/MAPK (red), PI 3-kinase (yellow), PLCγ (blue) and STAT (green). 
The negative regulator of the FGF signaling, Sprouty, is shown in brown. 
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It contains a phosphotyrosine-binding (PTB) domain and was shown to 
constitutively interact with the juxtamembrane region of the FGFR even without 
receptor activation. This interaction enables FRS2 phosphorylation and recruits 
another adaptor protein, Growth factor receptor-bound 2 (GRB2) and the 
guanidine nucleotide exchange factor (GEF) Son of sevenless (SOS) (Kouhara et 
al., 1997; Eswarakumar et al., 2005). These proteins in turn activate the 
membrane-bound GTPase Ras and facilitate the GTP-GDP exchange. This results 
in recruitment of an intracellular serin/threonin protein kinase cascade 
(MAPKKK/RAF; MAPKK/MEK and MAPK/ERK1/2) and leads to the activation of 
nuclear transcription factors (c-myc, AP1 or proteins of the E-twenty-six (ETS) 
family) and eventually to changes in gene expression (Böttcher and Niehrs, 2005; 
Turner and Grose, 2010). 
Moreover, a separate branch of FGF signaling involves GRB2-accociated 
binding protein 1 (GAB1), which recruits PI 3-kinase cascade and activates the 
cell survival pathway (Kouhara et al., 1997) (Figure 6). Another direction of the 
FGF pathway represents an FRS2-independent signaling cascade and involves 
phopholipase Cγ (PLCγ) (Figure 6). This signaling pathway was shown to be 
required for the rearrangement of actin cytoskeleton and cell migration (Böttcher 
and Niehrs, 2005; Turner and Grose, 2010). Depending on certain cellular 
context, the extracellular activation of FGFR may result in several other 
downstream pathways involving the P38 kinase, Jun N-terminal kinase and Signal 
transducer and activator of transcription (STAT) signaling (Boilly et al., 2000; 
Hart et al., 2000). The time required for the cell to respond to FGFR activation 
varies from several minutes, when the signaling results in rearrangement of actin 
cytoskeleton, to hours if it involves regulation of gene expression and requires 
protein biosynthesis (Alberts et al., 2002). 
 
1.3.2 Regulation of the FGF signaling 
FGF signaling is thoroughly regulated at several levels by extracellular and 
intracellular modulators. The extracellular regulation of FGF signaling is mediated 
by heparan sulfate proteoglycans (HSPGs). As already mentioned above, the 
extracellular carbohydrate chains of HSPGs interact with FGF ligands and stabilize 
their interaction with receptors, thus facilitating the signal transduction within the 
tissue. Several in vivo studies report about the biological relevance of HSPGs for 
FGF mediated signaling in vertebrates as well as in Drosophila (Garcia-Garcia and 
Anderson, 2003; Lin et al., 1999; Raman and Kuberan, 2010). 
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One of the specific intracellular antagonists of FGF-mediated signaling is 
Sprouty (Spry). This protein was first identified in Drosophila as a negative 
regulator of FGF signaling during tracheal development (Hacohen et al., 1998) 
and later was found to be conserved and play a similar role in mammals (Tefft et 
al., 1999). Spry carries a highly conserved cysteine-rich domain on the C-
terminus, which is essential for the protein recruitment to the plasma membrane 
and defines the inhibitory function (Lim et al., 2002). Spry expression is activated 
by FGF signaling, thus representing a negative feedback loop (de Maximy et al., 
1999). The negative regulation of FGF signaling by Spry was shown to occur at 
the level of Grb2 and Ras (reviewed in Christofori et al., 2003) (Figure 6). 
 
1.3.3 FGF signaling in Drosophila melanogaster 
There are two FGF receptors in Drosophila, Breathless (Btl) and Heartless 
(Htl), showing similar composition as the vertebrate FGFRs Btl receptor is 
expressed mainly in the tracheal cells and is responsible for the morphogenesis of 
tracheal branches during development of the embryonic tracheal system 
(Introduction 1.4.2; Glazer and Shilo, 1991; Reichman-Fried et al., 1994). Htl 
(Shishido et al., 1997; Gisselbrecht et al., 1996) is required for mesodermal cell 
migration during gastrulation and for the differentiation of mesodermal 
derivatives such as cardial and pericardial cells, somatic muscle founder cells, 
hemolymph and fat body cells (Mandal et al., 2004; Wilson et al., 2005). Bnl 
represents the only ligand for the Btl receptor (Sutherland et al., 1996), whereas 
Pyr and Ths were both shown to bind Htl (Stathopoulos et al., 2004; Gryzik and 
Müller, 2004). Similar to vertebrates, HSPGs were implicated in FGF signaling in 
Drosophila (Lin et al., 1999; Yan and Lin, 2007; Lindner et al., 2007). 
 Surprisingly, the Drosophila homologues of vertebrate adaptor proteins do 
not fulfill similar functions during Htl- and Btl-mediated FGF signaling. Instead, 
other components required for the intracellular propagation of the signaling were 
identified. One of them – downstream of FGFR (Dof) (also named Stumps (Sms) 
and Heartbroken (Hbr) (Michelson et al., 1998; Vincent et al., 1998; Imam et al., 
1999), was shown to participate in all biological processes that require FGF 
signaling and, similar to the vertebrate FRS2 protein, constitutively binds the 
intracellular domains of both Drosophila FGFRs (Wilson et al., 2004; Csiszar et 
al., 2010) (Figure 7). Dof does not show a homology to FRS2, but is related to 
other vertebrate adaptor proteins BCAP and BANK, which are responsible for B-
cell receptor signaling (Battersby et al., 2003). Upon binding the activated FGF 
receptor, Dof becomes phosphorylated at several tyrosine residues and recruits a 
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tyrosine phosphatase (PTP) Corkscrew (Csw) (Perkins et al., 1992; Petit et al., 
2004). This interaction is essential for downstream activation of the MAPK 
pathway via repression of Spry (Jarvis et al., 2006). In contrast to Dof, which is 
shown to function only downstream of FGF receptors, Csw is not specific for FGF 
signaling and was reported to regulate other RTK pathways, including EGFR and 
Torso signaling (Perkins et al., 1996; Jarvis et al., 2006). In addition, Dof 
contains a putative consensus motif for PI3K binding that was shown to be 
phosphorylated upon RTK activation. However, it is not clear whether this 
phophorylation activates the PI3K pathway (Csiszar et al., 2010). 
Drk (downstream of receptor kinase) is the Drosophila homolog of the 
vertebrate Grb2 adaptor protein and was shown to interact with RasGEF Son of 
sevenless (Sos) (Raabe et al., 1995) (Figure 7). It is probably recruited by the 
Dof protein upon FGFR activation. It was shown that Drosophila RasGAP (Ras 
GTPase activating protein) directly binds activated Btl and Htl receptors. This 
interaction attenuates FGFR-mediated signal transduction and was implicated in 
regulation of FGF signaling strength through the Ras/MAPK pathway (Woodcock 
and Hughes, 2004). However, since null mutants for the gene encoding Drosophila 
RasGAP, demonstrate no lethality, RasGAP function seems not to be essential for FGF 
signaling (Botella et al., 2003). 
 
 
 
 
 
 
 
 
 
 
Figure 7: FGF signaling pathway in Drosophila (adapted from Petit et al., 2004). A 
schematic representation of the Bnl/Btl signaling pathway. 
 
  INTRODUCTION 
_________________________________________________________________________ 
22 
 
 Not all FGF pathway routes have been identified to date and there are still 
some missing links to discover in the future. However, many identified proteins 
required for vertebrate FGF signaling appear to be highly conserved and 
functional in flies, proving high biological relevance of this pathway preserved 
through evolution. 
 
1.4 FGF signaling in Drosophila development 
Drosophila melanogaster represents an excellent model for studying the role 
of FGF signal transduction during embryogenesis due to the limited number of 
possible ligand-receptor interactions (Huang and Stern, 2005). FGF signaling is 
known to regulate formation and specification of the Drosophila mesoderm and 
branching morphogenesis during tracheal system development (Kadam et al., 
2009; Samakovlis et al., 1996a). 
 
1.4.1 FGF signaling in Drosophila mesoderm formation 
Mesoderm spreading in Drosophila relies on FGFR Heartless (Htl) and two 
FGFs, Thisbe (Ths) and Pyramus (Pyr). Lack of both FGF ligands causes 
embryonic lethality, whereas single mutants are semilethal and show defects in 
mesoderm invagination and differentiation (Stathopoulos et al., 2004; Gryzik and 
Müller, 2004; Kadam et al., 2009; Klingseisen et al., 2009). Gastrulation in 
Drosophila occurs with invagination of the ventral part of the blastoderm and 
formation of the mesoderm primordial structure that undergoes further cell 
movements and rearrangements, which require several factors (Figure 8). The 
fate of future mesodermal cells is defined by high nuclear level of the 
transcription factor Dorsal (DL) on the ventral site of the blastula (Leptin and 
Affolter, 2004). DL activates the expression of Twist (Twi) and Snail (Sna). Twi 
acts as a transcriptional activator and induces the expression of mesodermal 
markers in the ventral blastoderm. In contrast, Sna functions as a transcriptional 
repressor of ectodermal markers in the mesodemal primordium. The invagination 
of mesoderm is accompanied by changes in cell shape that is induced by Twi and 
Sna (Leptin, 1991; Leptin, 1999). 
Once inside the embryo, mesodermal cells first form an epithelial tube. 
However, later the cells lose their epithelial characteristics and intercellular 
contacts. They collectively migrate in the dorsolateral direction and spread out on 
the embryonic ectoderm forming a mesodermal monolayer (Leptin and Affolter, 
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2004). The disintegration of the mesodermal tube and spreading of the cells 
occur under the control of Htl signaling within the mesodermal cells (Figure 8). It 
was shown that Pyr is expressed in the dorsal ectoderm and provides an 
instructive cue for the migrating mesodermal cells (Kadam et al., 2009; 
Klingseisen et al., 2009). However, it seems that Pyr and Ths may function in a 
redundant manner in this process, since pyr mutant embryos show a weaker 
migration phenotype compared to htl mutants (Kadam et al., 2009; Klingseisen et 
al., 2009). Moreover, both FGF ligands are required in specification of the muscle 
progenitors during Drosophila development (Klingseisen et al., 2009). 
 
 
 
 
 
Figure 8: Drosophila gastrulation (adapted from Wilson and Leptin, 2000 and 
Stathopoulos et al., 2004). Schematic representation of gastrulation events in the 
embryo. Optical transverse crossections are shown. Arrows indicate the directions of 
gastrulational movement and mesoderm migration. (A) Invagination of the ventral 
blastoderm. (B) Mesoderm internalization and formation of the epithelial tube. Cells 
expressing the Htl receptor are marked in blue. (C) Disintegration of the tube and (D) 
spreading of the mesodermal cells along the embryonic ectoderm. The Pyr and Ths 
expressing cells are in yellow, The Htl-positive mesodermal cells are shown in blue (dark 
blue: cells with an activated MAPK cascade). 
 
Despite the overlapping functions during gastrulation, Ths and Pyr 
demonstrate distinct activities during mesoderm specification (Kadam et al., 
2009; Klingseisen et al., 2009). Pyr was shown to be required for the localized 
induction of even-skipped (Eve) expression in the dorsal mesoderm. This 
transcription repressor is involved in specification of subsets of pericardial and 
muscle cells on the dorsal side of the embryo (Smallhorn et al., 2004; Klingseisen 
et al., 2009). In addition, only Pyr was found to be essential for the formation of 
segment border muscles (SBMs) in Drosophila. These data suggest that Pyr 
function is more specialized compared to the function of Ths during early 
embryonic development (Klingseisen et al., 2009).  
Furthermore, it was reported that Drosophila adaptor protein Dof also 
contributes to the mesodermal spreading (Petit et al., 2004; Wilson et al., 2004; 
Klingseisen et al., 2009), indicating that the conserved FGF signaling is essential 
for gastrulation. Furthermore, the RhoGEF Pebble functions downstream of Htl, 
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indicating that FGF signaling directly affects cell shape changes (Schumacher et 
al., 2004). 
 
1.4.2 Role of FGF signaling in Drosophila tracheal development  
Drosophila Bnl/Btl signaling is essential for the morphogenesis of the 
tracheal system. Tracheal development is a complex morphogenetic process that 
relies on the crosstalk of many signaling pathways. Therefore, first an 
introduction to general steps of the Drosophila tracheal system development will 
be given, and then the molecular mechanisms underlying this process will be 
described. 
1.4.2.1 Development of Drosophila tracheal system 
Drosophila tracheal system development involves a number of 
developmental events including generation of epithelial tubes, their consequent 
elongation and branching. The fly respiratory organ represents a bilaterally 
symmetric system of interconnected epithelial tubules of different diameter, 
which deliver oxygen to almost every cell of a body. Air enters the system 
through special openings called spiracles (Uv et al., 2003; Cabernard et al., 
2004; Affolter and Caussinus, 2008). 
 
 
 
Figure 9: Development of Drosophila tracheal system (adapted from Cabernard et 
al., 2004). (A-D) Steps of the trachea formation in Drosophila embryo. Developing 
trachea is shown in red. Ten epithelial placodes arise on the both sides of the embryo. 
After two rounds of cell devision each metameric tracheal unit consists of ~80 cells. (A) 
Six primary branches grow out of the placode. (B-D) They elongate in different directions 
and some of them fuse together to form interconnected tubular network.  
 
Tracheal system development starts during Drosophila embryogenesis 
(embryonic stage 10) with the formation of 10 pairs of bilaterally symmetric epithelial 
clusters called tracheal placodes, each containing ~20 cells (Figure 9). The cells of 
each placode divide twice to generate about 80 tracheal cells. These cells do not divide 
again until the metamorphosis (Sato and Kornberg, 2002; Cabernard et al., 2005). 
Previously it was thought that the number of the tracheal cells remains stable, 
however, it was shown recently that some cells of the developing tracheal system 
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undergo apoptosis during their migration (Baer et al., 2009). All 20 tracheal pits 
invaginate to form inner epithelial sacs that give rise to tracheal tubes. This 
internalization is not complete, since the short stalk connects the tracheal sac to the 
body surface forming spiracular branches. The development of each tracheal unit 
occurs in a highly stereotypic manner and includes elongation of epithelial tubes 
(primary branch formation), bifurcation (secondary branch formation), sprouting of 
terminal branches and branch fusion (Uv et al., 2003; Cabernard et al., 2004; 
Affolter and Caussinus, 2008). 
 At stage 11 of embryogenesis cells of the tracheal pits start migrating in 
different directions and form six primary branches: the dorsal branch (DB), the 
dorsal trunk anterior and posterior (DTa and DTp), the visceral branch (VB), 
lateral branches anterior and posterior/ganglionic branch (LBa and LBp/GB) 
(Figures 10 and 11). Spiracular branches (SB) on each side on the body close 
later during embryogenesis. Primary tracheal branches build up the basic 
framework of the respiratory organ. During development every tracheal branch 
follows a certain growing pattern. Dorsal branches migrate dorsally towards the 
developing cardiac tissue. DTa and DTp branches grow in anterior and posterior 
directions respectively and eventually fuse together to form the dorsal trunk. 
Visceral branches grow towards the inner organs to deliver oxygen to the gut, 
whereas ganglionic branches elongate ventrally towards the central nervous 
system (CNS) (Samakovlis et al., 1996a; Uv et al., 2003) (Figure 10). 
 
 
 
 
 
 
 
 
Figure 10 Drosophila respiratory system (adapted from Uv et al., 2003). (A) 
Tracheal system of the late embryo visualized by the antibody against lumenal antigen. 
One of the tracheal metamers is shown in yellow. (B) Schematic drawing of the individual 
tracheal metamer. Multicellular primary branches are marked in grey. Unicellular terminal 
branches are in red. Fusion branches that interconnect tracheal metamers are in blue. 
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The process of branch growth includes cell elongation and rearrangement. 
During tube formation neighboring tracheal cells located side by side undergo 
controlled intercalation. This event is based on changes of cellular shape and 
remodeling of the adhesive junctions (AJ) and results in an assumption of an end-
to-end cell configuration (Ribeiro et al., 2004). 
 At stage 14 tracheal cells at the tip of each primary branch (leading cells) 
send unicellular outgrowths (secondary branches) that elongate and eventually 
form terminal branches (Figure 10). They represent blind-ended capillaries with 
an intracellular lumen that directly contact target tissues (Samakovlis et al., 
1996a; Uv et al., 2003). However, some secondary branches contact and fuse 
with tracheal cells of the neighboring metamere to generate an interconnected 
tubular network (Uv et al., 2003). These branches are called fusion branches 
(Figure 10). Branch fusion is a complex process that involves cell recognition and 
the formation of an intracellular lumen within the fusion cells (Samakovlis et al., 
1996b). 
Morphogenesis of the Drosophila respiratory system continues after 
embryonic development during larval and pupal stages. During the late larval 
period embryonic tracheal branches undergo extensive remodeling and give rise 
to the specialized structure called air sac primordium, whose cells proliferate and 
migrate to form the adult tracheal system (Sato and Kornberg, 2002; Cabernard 
et al., 2005; Chanut-Delalande et al., 2007). 
 
1.4.2.2 Regulation of tracheal system development in Drosophila 
Specification of tracheal precursor cells is under the control of several 
transcription factors including Tango (Tgo), Trachealess (Trh) and Ventral 
veinless (Vvl, also called Drifter) (Anderson et al., 1997; Llimargas and 
Casanova, 1997), whose expression starts at the stage 10 of Drosophila 
embryogenesis. Trh forms a heterodimer with Tgo and the expression of these 
factors determines tracheal cell fate (Boube et al., 2000; Brodu and Casanova, 
2006).  
The exact position of future placode invagination was shown to be strongly 
region-specific and is defined by the localized activity of several factors (Figure 
11). One of them is the zinc-finger transcription factor Spalt (Sal) (Kühnlein et 
al., 1994), whose activity restricts the area of the forming tracheal placode. 
Additionally, Sal participates in the dorsal trunk formation during later stages of 
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Drosophila embryogenesis (Kühnlein and Schuh, 1996). Trh also induces the 
expression of Rhomboid (Rho), a transmembrane protein that specifically cleaves 
and activates the EGF ligand Spitz (Lee et al., 2001a). EGF activity is responsible 
for the proper cellular movements during placode invagination and for subsequent 
migration of the tracheal cells (Figure 11). This pathway is also essential to 
maintain epithelial integrity during tracheal migration via cadherin-based cell-cell 
adhesion (Cela and Llimargas, 2006). Components of EGF signaling including 
Spitz ligand (Spi), Drosophila EGF receptor (DER) and Rho are involved in the 
regulation of the directional migration of tracheal cells along the AP body axis via 
induction of Sal expression. Thus, EGF signaling controls formation of the dorsal 
trunk and visceral branches (Llimargas and Casanova, 1999; Wappner et al., 
1997). 
Furthermore, the TGFβ homolog Dpp is expressed dorsally and ventrally of 
the initial place of placode invagination (Figure 11). Dpp signaling is required for 
the tracheal migration along the dorso-ventral axes and causes inhibition of Spalt 
function in the dorsal branches. Dpp interacts with receptor serine/threonine 
kinases Thick veins (Tkv) and Punt (Put) and locally controls Sal expression via 
the induction of Knirps (Kni) and Knirps-related (Knrl) zink finger transcription 
factors (Chen et al., 1998). Dpp signaling is required for the formation of dorsal 
branches, lateral trunk branches and ganglionic branches (Affolter et al., 1994; 
Vincent et al., 1997) (Figure 11). It was shown that rho and tkv double mutants 
demonstrate loss of all tracheal branches, consistent with the determined 
functions of these signaling pathways in tracheal development (Wappnes et al., 
1997). 
 
 
 
 
 
 
 
Figure 11: Involvement of patterning genes in specification of tracheal branches 
(adapted from Uv et al., 2003). (A) Localized expression of the signaling components 
of EGF (green), Wnt (yellow) and Dpp (red) pathways during early tracheal development. 
(B) Each patterning factor controls distinct subsets of tracheal branches. 
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Moreover, Wingless (Wg) signaling was shown to specify cell fate in the 
dorsal trunk via induction of Sal expression. Wg also promotes cell differentiation 
in all fusion branches (Chihara and Hayashi, 2000; Llimargas, 2000) (Figure 11). 
Furthermore, the components of Wnt/Wg, EGF or Dpp/TGF-β signaling pathways 
were shown to regulate the size, shape and branching pattern of individual 
tracheal branches. 
FGF signaling is essential for the directional migration of the tracheal 
branches and determination of branch-specific cell fate during Drosophila tracheal 
development. In the absence of one of the pathway components such as the Btl 
receptor, the Bnl ligand or protein tyrosine phosphatese Csw, tracheal branches 
do not migrate in the stereotypically defined manner and mutant embryos fail to 
form a normal tracheal system (Klämbt et al., 1992; Sutherland et al., 1996; 
Perkins et al., 1996). Moreover, mutations of sugarless and sulfatless, genes encoding 
enzymes involved in the synthesis and modification of heparan sulfate proteoglycans 
(HSPGs), also result in a migration disorder (Lin et al., 1999). Furthermore, similar 
tracheal phenotypes were observed in embryos lacking functional Dally-like, cell-
surface bound HSPG (Yan and Lin, 2007). 
Starting from stage 10 of embryogenesis all tracheal cells start to express 
the Btl receptor. At the same time Bnl is expressed in cell clusters surrounding the 
tracheal metamere. The Bnl ligand activates Btl in the nearby tracheal cells and 
induces directed migration and formation of the primary tracheal branches 
(Sutherland et al., 1996). 
 
 
 
 
 
 
Figure 12: Directional migration of the primary branches controlled by Bnl/Btl 
signaling (adapted from Uv et al., 2003). (A-C) Schematic representation of the 
developing tracheal metamere. Tracheal epithelium expressing the Btl receptor is shown 
in red; the Bnl FGF ligand is shown in blue. (A) Tracheal cells migrate in different 
directions and form six primary branches: the dorsal branch (DB), the dorsal trunk 
anterior and posterior (DTa and DTp), the visceral branch (VB), lateral branches anterior 
and posterior (LBa and LBp). (B, C) Once the tracheal branch reaches the source of Bnl, 
its expression fades (light blue circles) and appears in other developmentally programmed 
place. 
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In other words, Bnl serves as a chemoattractant for the tracheal cells (Figure 
12). Once the leading cell of the branch reaches the source of Bnl expression, its 
synthesis starts in other place according to the developmental pattern (Sutherland et 
al., 1996). Thus, Bnl/Btl signaling provides spatially and temporally regulated 
molecular cues critical for the stereotyped formation of the tracheal branches. Based 
on in vivo imaging experiments, it was shown that FGF-mediated signaling induces the 
generation of dynamic filopodia in tracheal cells, which probably contributes to the 
oriented cellular movements. Dynamic filopodia fail to form in animals, which lack Btl, 
Bnl or Dof activity. Moreover, ectopic expression of Bnl in the tracheal cells results in 
multiple filopodia formation (Ribeiro et al., 2002). Interestingly, the deletion analysis 
of the Dof adaptor protein suggests that MAPK activation is not required for the 
tracheal cell migration. This indicates that other FGF-mediated signaling pathways, 
including PI3K activation or PLCγ/calcium dependent intracellular cascade, may be 
involved in tracheal migration (Petit et al., 2004). 
FGF signaling is also required for secondary branching via induction of ETS-
transcription factor Pointed (Pnt) expression in the leading cells of the trachea, 
which is supposed to undergo bifurcation (Scholz et al., 1996). Pnt also plays a 
permissive role for the formation of terminal branches (Klämbt, 1993; Samakovlis 
et al., 1996a). The inhibitor of FGF signaling Spry is also involved in the 
secondary branching. Its expression is activated in the tracheal leading cells by 
Bnl/Btl signaling pathway. It functions non-autonomously and provides spatial 
restriction of FGF signaling in stalk cells preventing formation of additional 
branches (reviewed in Kim and Bar-Sagi, 2004). Embryos lacking Spry activity 
show formation of multiple ectopic terminal branches, suggesting that all tracheal 
cells assume the leading cell fate (Hacohen et al., 1998; Jarvis et al., 2006).  
During tracheal morphogenesis some of the leading cells become specialized 
as fusion cells (Tanaka-Matakatsu et al., 1996). Upon contact with the leading 
cell of the other branch the two branches fuse together with the consequent 
formation of the common lumen. Notch signaling functions as a negative 
regulator of fusion cell fate by the inhibition of MAPK activation and the loss of 
Notch activity was reported to cause ectopic branch fusions in Drosophila 
(Steneberg et al., 1999; Llimargas, 1999; Ikeya and Hayashi, 1999). 
Migration and fusion of the dorsal trunk branches, in addition to Bnl signals, 
require special mesodermal cells (bridge cells) that express the transcription 
factor Hunchback (Hb) (Wolf and Schuh, 2000). These cells are localized at the 
places where DTa and DTp branches meet and hb mutants demonstrate DT fusion 
defects. 
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Also, the terminal tracheal branches receive their specification through FGF-
mediated induction of Blistered (Bs, also Pruned and DSRF) expression. Bs 
promotes branch elongation and formation of fine cellular protrusions with an 
internal lumen that penetrate the target tissue (Guillemin et al., 1996). Slit/Robo 
signaling provides an additional control of terminal branch migration and was 
shown to repel tracheal cells from ventral midline (Englund, et al., 2002). 
Furthermore, the Bnl/Btl signaling was shown to play an essential role as 
mitogen and chemoattractant during larval trachea remodeling, shaping and 
guiding the newly appearing tracheal branches to their developmentally 
predetermined positions (Sato and Kornberg, 2002). However, formation of larval 
tracheal branches is additionally regulated by oxygen demand in the surrounding 
tissues. It was shown that Bnl expression is upregulated under hypoxic conditions 
and that induces additional tracheal growth towards the oxygen-starving tissue 
(Jarecki et al., 1999). Furthermore, FGF signaling in larvae is regulated by 
Drosophila matrix metalloproteinase 2 (Mmp2). Similar to Spry, it inhibits Bnl 
signaling in stalk cells in a non-autonomous manner. The target of the protease 
remains unknown, however, it was reported that the expression of Mmp2 in the 
tracheal cells is induced in response to FGF signaling building up the negative 
feedback loop (Wang et al., 2010). 
Taken together, the morphogenesis of the fly tracheal system involves the 
interplay of numerous instructive and limiting factors, whose spatial and temporal 
control helps to generate and shape an elaborated and highly ordered tubular 
organ. FGF signaling plays an essential role in this process and its modulated 
biological activity induces diverse cellular responses during the entire process. In 
this work, the developing trachea of Drosophila melanogaster serves as a model 
system to study the biological relevance of Bnl processing for its morphogenetic 
function.
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2 MATERIALS AND METHODS 
2.1 Molecular cloning 
2.1.1 Polymerase chain reaction  
Polymerase Chain Reaction (PCR) was used to produce DNA fragments for 
succeeding cloning. PfuUltra High-Fidelity DNA Polymerase (Stratagene) and 
PfuUltra II Fusion HS DNA Polymerase (Stratagene) were used for generation of 
the PCR product for cloning. HotStarTaq DNA Master Mix Kit (Qiagen) was used 
for analytical PCR. The chosen annealing temperature for each reaction was 
generally 5°C below the melting temperature of the designed primer pair. All 
PCRs were performed using Gene Amp 9700 PCR cycler (Applied Biosystems). 
 
2.1.2 DNA/RNA electrophoresis in agarose gel 
For purification or analysis of DNA or RNA fragments, they were subjected 
to electrophoresis in 0.8–2 % agarose gels with addition of ethidium bromide 
(Roth) in 0.5 % TBE buffer (Sambrook et al. 1989). DNA/RNA samples were 
loaded next to GeneRuler 1kb Plus DNA Ladder (Fermentas) to estimate relative 
size of the fragments. Stained DNA/RNA was visualized using UV-transilluminator 
(Raytest) at 366 nm. 
 
2.1.3 DNA gel extraction  
Desired DNA fragments were cut out from an agarose gel using a scalpel. 
DNA was extracted from the gel using QIAquick Gel Extraction Kit (Qiagen), 
according to the manufacturer’s protocol. 
 
2.1.4 Determination of DNA concentration 
1µl aliquots of DNA aqueous solution were used to estimate the 
concentration of DNA. All measurements were performed at 260 nm using 
NanoDrop 1000 Spectrophotometer (Thermo Scientific), according to the 
manufacturer’s manual. 
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2.1.5 DNA digestion with restriction endonucleases 
The reactions were carried out as described (Sambrook et al. 1989). For 
analytical purposes 1 µg of DNA was incubated with respective enzymes in total 
volume of 20 µl for 1–2 h. In preparative reactions 5 to 10 µg of DNA was 
digested in 50 µl volumes for 4h. All enzymatic digestion reactions were 
performed at 37°C. After restriction reaction DNA samples were purified using 
QiAquick Nucleotide Removal Kit (Qiagen), according to the manufacturer’s 
protocol, and eluted in 30–50 µl volume. 
 
2.1.6 Dephosphorylation of linearized vector DNA 
In order to prevent linearized vector DNA from self-ligation, 5’ phosphate 
groups were removed by treatment of DNA with an alkaline phosphatase 
(according to the protocol adapted from Sambrook et al., 1989). 1 µl of Shrimp 
alkaline phosphatase (SAP) (USB) was added to digested vector DNA samples in 
appropriate amount of SAP buffer (USB) and incubated at 37°C for 30 minutes. 
Afterwards, SAP was inactivated by heating DNA vector samples at 65°C for 15 
minutes. 
 
2.1.7 DNA ligation 
For a ligation reaction (adapted from Sambrook et al., 1989), 50–100 ng of 
linearized dephosphorylated vector was combained with a purified PCR fragment 
in a molar ratio 1:5, 1 µl of T4 DNA ligase (Fermentas) and appropriate volume of 
T4 DNA ligase buffer (Fermentas) in total volume of 10 to 30 µl. DNA ligation 
reactions were generally performed at room temperature for 1–2 h or overnight 
at 18°C. 
 
2.1.8 Gateway TOPO cloning 
For a directional cloning of blunt-end PCR fragments, pENTR Directional 
TOPO Cloning Kit (Invitrogen) was used. Cloning reactions were set up according 
to the manufacturer’s protocol. One Shot Top10 chemically competent E. coli 
cells, provided with the pENTR Directional TOPO Cloning Kit (Invitrogen) were 
used for further transformation of the cloning constructs. 
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2.1.9 Gateway LR recombination 
 For a LR recombination reaction, 50–100 ng of pENTR/D-TOPO vector 
containing the desired DNA insertion in the rfa-recombination cassette was 
combined with 100–150 ng of destination vector carrying a promoter sequence 
and 5’ or 3’ fusion tags. The reaction was set up and performed using LR Gateway 
recombination kit (Invitrogen) according to the manufacturer’s protocol. One Shot 
Top10 chemically competent E. coli cells (Invitrogen) were used for further 
transformation of the recombination constructs. 
 
2.1.10 Preparation of chemically competent E. coli cells 
Generation of chemically competent E. coli cells was performed according 
to Inoue et al., 1990. A single colony of XL1-blue E. coli cells was inoculated in 5 
ml of LB bacterial medium overnight at 37°C and agitation 200 rpm. 1 ml of 
overnight culture was transferred to 250 ml of fresh LB medium and cultured until 
an OD600 reaches 0.5–0.6. Then the culture was incubated on ice for 10–15 
minutes. All further steps were carried out on ice or at 4°C. E. coli cells were 
collected by centrifugation at 3500 rpm for 10 minutes. The cell pellet was 
resuspended in 10 ml of TB solution (10 mM PIPES, 15 mM CaCl2, 250 mM KCl, 
pH adjusted to 6.7 with KOH, then added 55 mM MnCl2). 70 ml of TB was added 
and the cells were kept on ice for 10–15 minutes. The cells were pelleted by 
centrifugation at 3500 rpm for 10 minutes and resuspended in 20 ml of TB with 
7% DMSO. After 10-15 minutes of incubation on ice the cells were aliquoted and 
flash-frozen in liquid nitrogen. The aliquotes were kept at -80°C until used for the 
transformation. 
 
2.1.11 Transformation of chemically competent E. coli cells 
 A heat-shock transformation was carried out according to Inoue et al., 
1990. An aliquot of chemically competent E. coli cells was thawed on ice and 5–
10 µl of ligation reaction or TOPO cloning mixture were added to the cells. After 
30 minutes of incubation on ice, the cells were subjected to the heat shock at 
42°C for 30 seconds and transferred back onto ice. The cells were incubated for 1 
hour in 800 µl of LB medium at 37°C with constant agitation. Then 100 µl of 
culture were plated on LB agar plates containing an appropriate antibiotic.  
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2.1.12 Site-directed mutagenesis 
 Point mutations of Bnl furin sites were introduced using Quick Change Site-
Directed Mutagenesis Kit (Stratagene). Oligonucleotides designed for 
mutagenesis contain desirable mutations and 15-17 nucleotides complementary 
flanking regions. Site-directed mutagenesis procedure was performed according 
to the manufacturer’s manual. Plasmid DNA isolated from resulting bacterial 
clones was sequenced to control for the presence of the nucleotide substitutions. 
 
2.1.13 Isolation of plasmid DNA 
 Plasmid DNA was isolated using QIAprep Plasmid Mini Kit (Qiagen) or 
QIAfilter Plasmid Midi Kit (Qiagen). A single colony of transformed E. coli cells 
was inoculated overnight at 37°C with constant agitation in 3–5 ml of LB medium 
containing selective antibiotic. Next day the cells were collected by centrifugation 
at 4000 rpm for 15 minutes. The plasmid preparation procedure was performed 
according to the protocol supplied by manufacturer. 
 
2.1.14 Sequencing of DNA 
 DNA samples for sequencing contained each 0,7–1 µg of plasmid DNA that 
was either lyophilized or diluted in 15 µl of pure water. Oligonucleotides were 
diluted to 2 pmol/µl and supplied in volume of 15 µl. DNA sequencing was 
performed in sequencing facility of MWG-Biotech AG. 
 
2.1.15 Generation of cDNA library from Drosophila Kc cells  
Total RNA was isolated form Drosophila cultured cells using RNeasy Mini 
RNA purification Kit (Qiagen), according to the manual provided by the 
manufacturer. QuantiTect Reverse Transcription Kit (Qiagen) was utilized for in 
vitro cDNA synthesis. The reaction was set up and performed according to the 
manufacturer’s protocol.  
 
2.1.16 Semi-quantitative PCR 
To estimate the efficiency of dsRNA silencing of furin genes in Drosophila 
Kc cells, semi-quantitative PCR was performed using 10 ng of different Kc cDNA 
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library samples as templates. The PCR reactions were set up using gene-specific 
primer pairs and HotStarTaq DNA Master Mix Kit (Qiagen), according to the 
manufacturer’s manual. Resulting PCR products were analyzed in 1,5-2% agarose 
gel as described in section 2.1.2. The acquired image of DNA bands was 
subjected to quantitative analysis of DNA intensity as described in section 2.5.3. 
 
2.1.17 Preparation of single-stranded RNA in situ probes 
 5-10 µg of plasmid DNA containing gene of interest and 3’ RNA polymerase 
promoter was linearized using a unique restriction site within the insert located 
500-1000 bp upstream of RNA promoter. The digestion reaction was performed as 
described in section 2.1.5. The linearized plasmid was purified with QiAquick 
Nucleotide Removal Kit (Qiagen), according to the manufacturer’s protocol, and 
eluted in 30–50 µl volume. The digoxygenin (DIG) labeled RNA probe was 
generated using linearized DNA template and DIG RNA labeling kit (Sp6/T7) 
(Roche), according to the protocol provided by the manufacturer. The synthesized 
single-stranded RNA probe was purified using RNeasy Mini kit (Qiagen), according 
to the manufacturer’s manual. The RNA probe was visualized on 2% agarose gel 
as described in section 2.1.2. The probe was mixed with one volume of Hybe 
buffer (50% Formamide, 5x SSC, 5 µg/ml Heparin, 0,2 mg/ml sonicated salmon 
testis DNA, 0,1 mg/ml tRNA) and kept at -20/-75ºC. 
 
2.1.18 Preparation of double-stranded RNA for transfection of Kc cells 
 The DNA templates for dsRNA synthesis were generated by PCR. Resulting 
short PCR products contain two opposing T7 promoters. In vitro synthesis of 
dsRNA was performed using MEGAscript T7 Transcription Kit (Ambion) according 
to the manual supplied by manufacturer. Resulting dsRNA was purified with 
RNeasy mini RNA purification kit (Qiagen) according to the manufacturer’s 
protocol. 
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2.2 Cell biology methods 
2.2.1 Maintenance of Drosophila cultured cell lines 
Drosophila Kc167 (Drosophila Genomics Resource Center (DGRC), Echalier 
and Ohanessian, 1970) embryonic cell line was maintained in Schneider’s 
Drosophila medium (Gibco) supplemented with 100 µg/ml of 
penicillin/streptomycin (PAA Labs) and 10% of fetal calf serum (Sigma Aldrich). 
The cells were cultured in 25 cm2 flasks or 10 cm2 plates at 25ºC. 
 
2.2.2 Transient transfection of Drosophila Kc cells 
Confluent Drosophila Kc cells were plated at a concentration of 1x105–
5x105 cells/ml on 6-well (2 ml per well) or 12-well (1 ml per well) cell culture 
plates. The cells were grown overnight before the transfection. The transfection 
was performed next day using the Effectene Transfection Kit (Qiagen). The 
manufacturer’s protocol was adjusted for Drosophila cells. 1 µg of plasmid DNA 
was combined with 200 µl of EC buffer, 20 µl of Enhancer reagent, 8 µl of 
Effectene reagent and the appropriate volume of cell medium per one well of 6-
well plate. The amount of DNA and reagents was scaled down by half for the 
transfection of 12-well plate. The resulting mixture was added drop-wise onto the 
cells. Next day, the cells were carefully washed with 1x PBS buffer (1,7 mM 
KH2PO4, 5,2 mM Na2HPO4, 150 mM NaCl) and serum-free medium with or without 
proteinase inhibitor cocktail (Complete Proteinase Inhibitor Cocktail Tablets, 
Roche) was added. The cells were incubated at 25ºC for 1 or 2 days. Then the 
supernatant and cells were harvested for further analysis. 
 
2.2.3 Knock-down of endogenous gene expression by dsRNA  
Drosophila Kc cells were split and plated onto 12-well plate at a 
concentration 1-1,5x106 cells/ml. The cells were allowed to settle for 45 minutes 
in serum-free medium. Then the medium was substituted with the complete 
Schneider’s medium with 10% of fetal calf serum, which contained 10 µg of 
dsRNA. The cells were incubated at 25ºC. After 3-4 days dsRNA treated cells were 
either additionally transfected with plasmid DNA as described in section 2.2.2 or 
harvested for subsequent analysis. 
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2.2.4 Receptor-ligand binding assay in Drosophila embryonic cells 
Kc cells were transfected separately with receptor (pUbi-FLAG-Btl) or Bnl 
(pUbi-EGFP-Bnl-Myc) DNA constructs as described in section 2.2.2. One day 
before the assay, the receptor-expressing cells were plated on the cover slips and 
allowed to settle overnight. Next day, cell supernatants containing secreted Bnl 
molecules were collected and centrifuged at 1500 rpm for 10 minutes to get rid of 
the residual cells. The conditioned medium of receptor expressing cells were 
substituted with the cell-free Bnl supernatants and the cells were incubated at 
4ºC for 2 hours with slow agitation to allow specific binding of Bnl ligands to the 
cell-surface Btl receptors. Afterwards, the cells were subjected to the fluorescent 
immunostaining. 
 
2.2.5 Immunostaining of Drosophila cells 
The cells on the cover slips were washed 3 times with ice-cold 1x PBS 
buffer and fixed in 4% paraformaldehyde (PFA) solution in 1x PBS at room 
temperature for 10 minutes. Afterwards, the cells were thoroughly washed 3 
times for 15 minutes with 1x PBT buffer and subsequently blocked using 1x PBT 
with 10% of goat serum (Sigma Aldrich). Then the cover slips were incubated for 
30 minutes with primary anti-GFP and anti-FLAG antibodies in 1x PBT with 5% 
goat serum at room temperature with slow agitation. The cells were subsequently 
washed 3 times for 15 minutes in 1x PBT and incubated for 30 minutes with 
fluorescently coupled secondary antibody at room temperature with slow 
agitation. Finally, the stained cells were washed 3 times for 15 minutes in 1x PBT 
and the cover slips were mounted on the microscopic slides in Vectashield 
mounting medium with DAPI (Vector Laboratories). The slides were sealed with 
transparent nail polish and kept at 4ºC until used for fluorescent microscopy. 
 
2.2.6 Fluorescent scanning confocal microscopy of Drosophila cells 
The stained Kc cells were analyzed on Leica TCS SP2 LSM confocal 
microscope (Leica Microsystems) using 488 nm and 568 nm excitation light. The 
images were acquired with 40x magnification oil objective. 
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2.2.7 Preparation of cell lysates for Western blot analysis 
Transfected cells were washed twice with 1x PBS buffer. Then the cells 
were harvested and lysed in 1x loading buffer (50 mM Tris-HCl pH 6.8, 1% SDS, 
~0,01% bromphenol blue, 50 mM Dithiothreitol (DTT), 5% Glycerol) and kept at -
20ºC until analysed by Western blot. 
 
2.2.8 Preparation of cell supernatants for Western blot analysis 
Drosophila cells were grown and transfected as described in section 2.2.2. 
Afterwards, supernatants of transfected cells were collected and centrifuged at 
1500 rpm at room temperature to get rid of residual cells. Then the supernatants 
were concentrated using Vivaspin 2 centrifugal protein concentrators (10.000 
MWCO PES, Vivascience AG). Alternatively, cell-free supernatants were 
concentrated using trichloracetic acid (TCA) protein precipitation. 100% TCA (500 
g TCA, 227 g water) was added to 10-15% concentration to the supernatant 
samples and mixed well. The samples were kept at -20ºC for 30 minutes to 
induce protein precipitation. The precipitates were collected by centrifugation at 
15000 rpm at 4ºC for 10 minutes. The resulting pellets were washed with ice-cold 
acetone (Merck Chemicals), air-dried for 5 minutes and dissolved in 50-100 µl of 
1x loading buffer. The concentrated supernatant samples were subsequently 
analyzed by Western blot (see Materials and methods sections 2.3.2-2.3.4). 
 
2.3 Proteomic methods 
2.3.1 Enzymatic protein N-deglycosylation 
Enzymatic N-deglycosylation reaction (according to Tarentino and 
Plummer, 1994) was employed to remove sugar moieties attached to asparagine 
residues of the protein chain. Protein N-deglycosydase F (PNGase F, Sigma 
Aldrich, Plummer et al., 1984) was used for this purpose. 45 µl of concentrated 
cell supernatant was mixed with 5 µl of the denaturing buffer (0,2% SDS, 100 
mM 2-mercaptoethanol). The solution was heated at 100ºC for 10 minutes to 
denature the proteins and then cooled down to the room temperature. Then 5µl 
of 15% Triton-X100 and 5 µl of PNGase F were added to the solution. The mixture 
was incubated at 37ºC for 1-2 hours. The enzymatic reaction was stopped by 
heating at 100ºC for 5 minutes. Deglycosylated supernatant samples were 
subjected to Western blot analysis. 
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2.3.2 SDS protein electrophoresis (modified from Laemmli, 1970) 
Protein polyacrylamide gels (PAGEs) containing different concentrations of 
acrylamide were precast using 8%, 10% or 15% resolving gel solution (375 mM 
Tris-Cl pH 8.8, 0,1% SDS, 0,1% ammonium persulfate (APS), 0,08% 
tetramethylethylendiamin (TEMED), appropriate percentage of 30% acrylamide-
bisacrylamide solution) and stacking gel solution (4% acrylamide, 130 mM Tris-Cl 
pH 6.8, 0,1% SDS, 0,1% APS, 1µg/ml TEMED). Protein samples were mixed with 
4x loading buffer and heat at 95ºC for 5 minutes. Then the samples were run on 
PAAG along with PageRuler Plus Prestained Protein Ladder (Fermentas) using Mini 
Protean II System (Bio Rad). Protein electrophoresis was performed at a constant 
voltage of 80-110 V in 1x Tris-Glycine buffer (25 mM Tris, 250 mM Glycine, 0,1% 
SDS) until the dye front reached the gel bottom. 
 
2.3.3 Tricine-SDS protein electrophoresis 
Tricine-SDS PAGE electrophoresis (according to Schägger and Von Jagow, 
1987) was employed for the efficient separation of low molecular weight proteins. 
The 15% polyacrylamid gel was precast as described in section 2.2.10. The 
electrophoresis was run using 1x Cathode buffer (0,1M Tris, 0,1M Tricine, 0,1% 
SDS) and 1x Anode buffer (0,2 M Tris-Cl pH 8.9) in Mini Protean II System (Bio 
Rad) at a constant voltage of 90-150 V. 
 
2.3.4 Protein immunodetection by Western blot 
Protein gels after electrophoresis were blotted on a polyvinylidenfluorid 
(PVDF) (Millipore) membrane activated by 30 seconds incubation in methanol. 
Protein blotting was performed in 1x Transfer buffer (25 mM Tris, 250 mM 
Glycine, 10% methanol) using Mini Protean II System (Bio Rad) at a constant 
voltage of 45 V for 1 hour 40 minutes. All subsequent steps were performed on a 
shaker unless mentioned otherwise. The membrane was shortly washed in 1x PBT 
buffer (1x PBS with 0,01% Tween-20) and blocked for 2 hours in 1x Blocking 
buffer (Sigma Aldrich) to diminish a cross-reactivity of antibody. The membrane 
was incubated overnight at 4ºC with primary antibody at appropriate 
concentration in 1x Blocking buffer. Next day, the membrane was washed 3 times 
for 15 minutes with 1x PBT and subsequently incubated with HRP-coupled 
secondary antibody for 1 hour. Finally, the membrane was washed 3 times for 15 
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minutes in 1x PBT buffer. The specific chemiluminescent signal was developed 
using SuperSignal West Dura Extended Duration Substrate (Thermo Scientific), 
according to the manufacturer’s protocol. The image was acquired using LAS 1000Plus 
IDX2 Intelligent Dark Box II luminescence detector (Fujifilm). In order to reprobe the 
same membrane with different primary and secondary antibodies, it was subjected to 
the stripping procedure to wash away bound antibody using Western blot striping 
buffer (Thermo Scientific). Then the membrane was washed 3 times for 15 minutes 
with 1x PBT buffer and incubated with the new antibody as described above. 
 
2.4 Drosophila techniques 
2.4.1 Maintenance of Drosophila melanogaster strains 
 Fruit flies were maintained and bred in the fly vials on a food medium 
containing corn flour-soya, flour-molasses and dry yeast. The vials were kept at 25ºC 
and 20-30% humidity. 
 
2.4.2 Generation of stable transgenic fly lines 
 Transgenic Drosophila lines were generated using site-specific P-element 
mediated germline transformation (Bischof et al., 2007) at the cytolocation 86F 
on the third chromosome. Plasmid DNA for injection was isolated and purified as 
described in section 2.1.13. Embryo injections were performed in BestGene Inc. 
(California, USA). Freshly eclosed transformed flies were identified by the red eye 
color introduced by a mini-w+ marker gene in the P-element insertion. The flies 
were further crossed to a “balancer” fly lines for the third chromosome w1118;; 
D3/TM6B Hu or w1118;; D3/TM3 Ser.  
 
2.4.3 UAS/GAL4 system for ectopic gene expression 
 UAS/GAL4 system was utilized to induce spatially- and temporary-specific 
gene expression in Drosophila embryo (Brand and Perrimon, 1993). The system 
relies on the yeast transcription factor GAL4 that interacts with upstream 
Activating Sequence (UAS) and activates expression of a downstream target 
gene. During the experiment, transgenic flies carrying gal4 coding sequence 
downstream of a tissue-specific promoter were mated with a fly line encoding 
gene of interest fused downstream of UAS element. The resulting progeny show 
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certain temporal and spatial pattern of target gene expression controlled by a 
specific promoter upstream of gal4 sequence. 
 
2.4.4 Collection and fixation of Drosophila embryos 
 Drosophila embryos were collected on agar-apple juice plates 
supplemented with yeast for 14-20 hours at 25ºC. The embryos were harvested 
from the plates using a brush and thoroughly washed with 1x Embryo wash buffer 
(10 mM NaCl, 0,01% Triton X-100) to get rid of the residual yeast. Then the 
embryos were dechorinated with 50% bleach and washed again with 1x Embryo 
wash buffer. Afterwards, they were fixed in 1 ml of RNA-fix solution (10% 
paraformaldehyde, 50 mM EGTA) with addition of 6 ml of heptane for 20 minutes 
on a rocking platform. Then the aqueous fixing solution was discarded and the 
embryos were devitellinized by adding of 5 ml of methanol to the residual 
heptane phase and thoroughly mixing for 15 seconds. Devitellinized embryos 
were washed 3 times with methanol and stored at 4ºC  
 
2.4.5 Embryo immunostaining 
 All steps were performed at room temperature with constant rotation 
unless mentioned otherwise. Fixed Drosophila embryos were rehydrated by 
washing 3 times with 1x PBT buffer (described in section 2.3.4). Then the 
embryos were incubated with primary antibody at appropriate concentration 
overnight at 4ºC on a rotator. Next day the embryos were washed several times 
with 1x PBT buffer and blocked for 1 hour using 10% goat serum to prevent 
cross-reactivity of antibody. Afterwards, secondary antibodies at appropriate 
dilution were added and the embryos were incubated for 2 hours. Then the 
embryos were washed 3 times for 15 minutes with 1x PBT buffer. For the signal 
amplification, the embryos were incubated with ABC Elite PK6100 Kit (Vector 
Laboratories). The reaction was prepared by mixing of 10 µl of solution A and 10 µl of 
solution B in 500 µl of 1x PBT buffer half an hour in advance. The embryos were 
incubated with the reaction mixture for 30-45 minutes. After thorough washing with 
1x PBT a specific staining was developed with SIGMAFASTTM3,3’-Diaminobenzidine 
tablets (Sigma Aldrich) detecting peroxidise activity of HRP-coupled secondary 
antibody. The reaction was terminated by washing 3 times with 1x PBT buffer. In case 
when alkaline phosphatise-coupled secondary antibodies were used, the embryos were 
additionally washed with 1 ml of alkaline phosphatase (AP) buffer (200 mM Tric-Cl pH 
9.5, 100 mM NaCl, 50 mM MgCl2) and a specific blue staining was developed by 
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incubation of the embryos with 4,5 µl 4-Nitro blue tetrazolium chloride (NBT, 
Roche)/3,5 µl 5-Bromo-4-chloro-3-indolyl-phosphate (X-phosphate, Roche) mixture in 
1 ml of AP-buffer for 10-45 minutes without rotation. The precipitation reaction was 
stopped by washing 3 times with 1x PBT buffer. The immunostained embryos were 
dehydrated in absolute ethanol and individually mounted in Canada balsam (Sigma 
Aldrich). 
 
2.4.6 Whole-mount RNA in situ hybridization of Drosophila embryos 
 All steps were performed at room temperature with rotation unless 
mentioned otherwise. Fixed embryos were washed with methanol and then with 
50% methanol in 1x PBT buffer. Then the embryos were additionally fixed for 20 
minutes with RNA-fix solution half diluted with 1x PBT. After washing 3 times with 
1x PBT buffer, the embryos were rinsed with 250 µl of HybeB solution (50% 
Formamide, 5x SSC) for prehybridization. Then HybeB solution was substituted 
with 250 µl of Hybe solution (described in section 2.1.17). Afterwards, the 
embryos were incubated for 1 hour with 500 µl of fresh Hybe at 68ºC in the water 
bath. Then Hybe solution was discarded and 1-5 µl of DIG labelled RNA probe in 
30 µl of Hybe was added to the embryos. Hybridization was performed overnight 
at 68ºC in water bath. Next day embryos were washed twice with 500 µl of warm 
Hybe solution at 68ºC and once with HybeB solution. Then embryos were 
transferred to room temperature and washed several times with 1x PBT for 5-15 
minutes to remove the residual RNA probe. Anti-DIG alkaline phosphatise-coupled 
secondary antibody was added and the embryos were incubated for 2h on a 
rotator. After thorough washing with 1x PBT buffer, the embryos were rinsed and 
washed with 1 ml of AP buffer. Alkaline phosphatase staining was developed as 
described in section 2.4.5. The reaction was terminated by washing of the 
embryos with 1x PBT several times for 15 minutes. Stained embryos were then 
dehydrated in absolute ethanol and mounted in Canada balsam. 
 
2.4.7 Preparation of embryo lysates for Western blot analysis 
 Drosophila embryos were collected from the agar-juice plates and washed 
with 1x embryo wash buffer. The embryos were dechorionated in 50% bleach for 
3 minutes and thoroughly washed with 1x embryo wash buffer. The residual liquid 
was removed and the tubes with embryos were flash-frozen in liquid nitrogen. 
The embryos were stored at -20ºC until used. Frozen embryos were squashed in 
cold 1x PBS supplemented with protease inhibitor cocktail and subjected to 
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ultrasound treatment using Bioruptor (Diagenode). The sonication was performed 
several times for 30 seconds with 1 minute intervals and total time of 5-7 
minutes. Then 4x loading buffer was added to the samples. The lysates were 
vortexed well and heat at 95ºC for 10 minutes. Finally, the samples were 
centrifuged for 30 minutes at 15.000 rpm at 4ºC. Resulting pellets and 
supernatants were separated and kept at -20ºC before analyzed by Westen blot 
with appropriate antibody.  
 
2.4.8 Bright field microscopy of Drosophila embryos 
 Stained embryos were analysed using Zeiss Axiophot microscope (Carl 
Zeiss AG) with x10 or x20 magnification objectives.  
 
2.5. Computed methods 
2.5.1 Primer design 
 Oligonucleotides for molecular cloning and site-directed mutagenesis were 
designed using Primer3Plus online tool (Untergasser et al. 2007). 
 
2.5.2 Alignment of protein sequences 
 In silico alignment of protein sequences and estimation of their homology 
was performed using ClustalW2 (EBI) (Mackey et al., 2002) and Blastp 2.2.18 
(Altschul et al., 1997) online recourses. 
 
2.5.3 Quantitative analysis of intensity of DNA bands 
 Digital image of DNA bands after semi-qantitative PCR reaction (described in 
section 2.1.16) was analysed using ImageJ software (Abramoff et al., 2004). The 
intensity of each band was quantified and the resulting reference and test values were 
compared with each other to estimate the efficiency of gene silencing. 
 
2.5.4 Prediction of N- and O-linked glycosylation sites 
 Prediction of potential sites for N-linked protein glycosylation was performed 
using the NetNGlyc 1.0 Server online resource (Gupta et al., 2004). O-linked protein 
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glycosylation sites were predicted using the OGPET 1.0 online prediction tool 
(http://ogpet.utep.edu/OGPET; University of Texas at El Paso). 
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2.6 List of oligonucleotides 
Oligo 
number Oligonucleotide name Sequence (5’-3’) 
TKO1 ol.bnl-entry F CACCATGCCCCTCATGGCCATGGA 
TKO2 ol.bnl-entry R CAGGATGGCTCTTTTTCGGA 
TKO3 ol.bnlFL-entry F CACCATGCGAAGAAACCTGCGC 
TKO4 ol.WgSP F GACACTAGTATGGATATCAGCTATATCTT 
TKO5 ol.WgSP R GTAGCTAGCCATGGAGCCCCGGCCCCTTC 
TKO6 ol.btl-entry F CACCTGCGATTATGGCCATCATCG 
TKO7 ol.btl-entry R ATTAAACTTATAGGTGTACTG 
TKO8 ol.bnlN-entry R CTAGGACTGTGGCACCGTGGA 
TKO9 ol.bnlFGFstop-entry R CTAGATGGCGTTCGTGTAGGT 
TKO10 ol.bnlFGF-entry R GATGGCGTTCGTGTAGGT 
TKO11 ol.bnlSSL-entry F CACCAGTAGTCTTAACATAAATA 
TKO12 ol.bnlSSN-entry F CACCAGCAGTAACACGCCCATCAG 
TKO13 ol.bnlSNL-entry F CACCAGCAATCTGGACCGTAACGA 
TKO14 ol.bnlNER-entry F CACCAACGAACGATCCACGGTGCC 
TKO15 ol.bnlSTV-entry F CACCTCCACGGTGCCACAGTCCC 
TKO16 ol.bnlHLA-entry F CACCCATTTGGCCTGGACCTCGCG 
TKO17 ol.bnlR233G F GCCCATCAGCAATCTGGACGGTAACGAACGATCC
ACGGTGC 
TKO18 ol.bnlR233G R GCACCGTGGATCGTTCGTTACCGTCCAGATTGCTG
ATGGGC 
TKO19 ol.bnlR236G F GCAATCTGGACCGTAACGAAGGATCCACGGTGCC
ACAGTC 
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TKO20 ol.bnlR236G R GACTGTGGCACCGTGGATCCTTCGTTACGGTCCA
GATTGC 
TKO21 ol.bnlR233GR236G F CCATCAGCAATCTGGACGGTAACGAAGGATCCAC
GGTGCCACA 
TKO22 ol.bnlR233GR236G R TGTGGCACCGTGGATCCTTCGTTACCGTCCAGATT
GCTGATGG 
TKO23 ol.dfur1_RT F TCGGACACTATACCCAC 
TKO24 ol.dfur1_RT R CGCGATCGTCGTCATCC 
TKO25 ol.dfur2_RT F GTTTGGGCCTCTGGCAAC 
TKO26 ol.dfur2_RT R CATGTCGACGGTGGCGAC 
TKO27 ol.bnlR164S F TCCTGTCGCGTACCGAAAGCAGCATTCGTCACCAG 
TKO28 ol.bnlR164S R CTGGTGACGAATGCTGCTTTCGGTACGCGACAGG
A 
TKO29 ol.bnlR642GR645G F CAAATCCATTTCCGGTGGCAAGGGGAAGCATGGG
AAATTGGATGCAAGTACCAC 
TKO30 ol.bnlR642GR645G R GTGGTACTTGCATCCAATTTCCCATGCTTCCCCTT
GCCACCGGAAATGGATTTG 
TKO31 ol.bnlR687GR690G F GAAACCAGCGATAGGGTGGAGGGCAACGTGGGC
ATGAGCAGCGGCGAGGAGCAG 
TKO32 ol.bnlR687GR690G R CTGCTCCTCGCCGCTGCTCATGCCCACGTTGCCCT
CCACCCTATCGCTGGTTTC 
TKO33 ol.bnlSTV-KpnI-F GACGGTACCTCCACGGTGCCACAGTCC 
TKO34 ol.bnlSTV-KpnI-R ACGGTACCTTACAGGATGGCTCT 
TKO35 ol.bnlGGKKpnI-R GACGGTACCCTTGCCACCGGAA 
TKO36 ol.bnlSP-BglII-F GCAGATCTATGCGAAGAAACCTG 
TKO37 ol.bnlSP-XhoI-R ATCTCGAGCGCAGATACAAGGCC 
TKO38 ol.bnlN-XhoI R ATCTCGAGGGATCGTTCGTTACGGTCCAG 
TKO39 ol.EGFP-XhoI F AGCTCGAGATGGTGAGCAAGGGCGAG 
TKO40 ol.EGFP-XhoI R TACTCGAGCTTGTACAGCTCGTCCA 
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2.7 List of plasmid DNA 
 
Plasmid 
number 
Insert Vector Preparation 
TKP1 bnl ORFΔ1-93 bps pENTR/D-TOPO PCR with TKO1/2, TOPO-
cloning 
TKP2 WgSP pUbi-EGFP-rfA PCR with TKO4/5, cloning via 
SpeI 
TKP3 10x Myc tag pUbi-WgSP-EGFP-
rfA 
Subcloning via NheI site 
TKP4 10x Myc tag pUbiP-rfA Subcloning via NheI site 
TKP5 bnl ORF Δ1-93 bps pUbi-WgSP-EGFP-
rfA-Myc 
LR recombination of TKP3 
with TKP1 
TKP6 bnl ORF pENTR/D-TOPO PCR with TKO2/3, TOPO-
cloning 
TKP7 bnl ORF pUbi-rfA-Myc LR recombination of TKP4 
with TKP6 
TKP8 WgSP-EGFP-rfA-
Myc cassette 
pUASTattB Cloning via XbaI site 
TKP9 bnlN (bnl ORF 94-
726 bps) 
pENTR/D-TOPO PCR with TKO1/8, TOPO 
cloning 
TKP10 bnlFGFstop (bnl 
ORF 94-1131 bps 
with Stop-codon) 
pENTR/D-TOPO PCR with TKO1/9, TOPO 
cloning 
TKP11 bnlFGF (bnl ORF pENTR/D-TOPO PCR with TKO1/10, TOPO 
TKO41 ol.XhoI-STV ATCTCGAGTCCACGGTGCCACAGTCC 
DRSC31
247_R 
ol.sec23#47 F  
(from Mathias Beller) 
gtaatacgactcactataggGTTCGGCGAGTACTCAAAGG 
 
DRSC31
247_S 
ol.sec23#47 R  
(from Mathias Beller) 
gtaatacgactcactataggTGGCATGTCCTGGTATTTGA 
DRSC31
248_S 
ol.sec23#48 R  
(from Mathias Beller) 
gtaatacgactcactataggCTCGGAAATGGCAGCATATT 
DRSC31
248_R 
ol.sec23#48 F  
(from Mathias Beller) 
gtaatacgactcactataggTTACCAGCCTTTGAAGGAGC 
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94-1131 bps) cloning 
TKP12 bnlN (bnl ORF 94-
726 bps) 
pUbi-WgSP-EGFP-
rfA-Myc 
LR recombination of TKP9 
with TKP3  
TKP13 bnlFGFstop (bnl 
ORF 94-1131 bps 
with Stop-codon) 
pUbi-WgSP-EGFP-
rfA-Myc 
LR recombination of TKP10 
with TKP3  
TKP14 bnlFGF (bnl ORF 
94-1131 bps) 
pUbi-WgSP-EGFP-
rfA-Myc 
LR recombination of TKP11 
with TKP3  
TKP15 3x FLAG tag pUbi-rfA-Myc Cloning via SpeI 
TKP16 WgSP pUbi-FLAG-rfA-Myc PCR with TKO4/5, cloning via 
SpeI 
TKP17 bnlSSL pENTR/D-TOPO PCR with TKO11/2, TOPO 
cloning 
TKP18 bnlSSN pENTR/D-TOPO PCR with TKO12/2, TOPO 
cloning 
TKP19 bnlSNL pENTR/D-TOPO PCR with TKO13/2, TOPO 
cloning 
TKP20 bnlNER pENTR/D-TOPO PCR with TKO14/2, TOPO 
cloning 
TKP21 bnlSTV pENTR/D-TOPO PCR with TKO15/2, TOPO 
cloning 
TKP22 bnlHLA pENTR/D-TOPO PCR with TKO16/2, TOPO 
cloning 
TKP23 bnlSSL pUbi-WgSP-FLAG-
rfA-Myc 
LR recombination of TKP16 
with TKP17 
TKP24 bnlSSN pUbi-WgSP-FLAG-
rfA-Myc 
LR recombination of TKP16 
with TKP18  
TKP25 bnlSNL pUbi-WgSP-FLAG-
rfA-Myc 
LR recombination of TKP16 
with TKP19 
TKP26 bnlNER pUbi-WgSP-FLAG-
rfA-Myc 
LR recombination of TKP16 
with TKP20  
TKP27 bnlSTV pUbi-WgSP-FLAG-
rfA-Myc 
LR recombination of TKP16 
with TKP21 
TKP28 bnlHLA pUbi-WgSP-FLAG-
rfA-Myc 
LR recombination of TKP16 
with TKP22  
TKP29 bnlSSL pUbi-WgSP-EGFP-
rfA-Myc 
LR recombination of TKP17 
with TKP3 
TKP30 bnlSSL(R233G) pUbi-WgSP-EGFP- Site-directed mutagenesis 
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rfA-Myc using TKO17/18 
TKP31 bnlSSL(R236G) pUbi-WgSP-EGFP-
rfA-Myc 
Site-directed mutagenesis 
using TKO19/20 
TKP32 bnl ORF Δ1-93 bps 
(R164S) 
pUbi-WgSP-EGFP-
rfA-Myc 
Site-directed mutagenesis 
using TKO27/28 
TKP33 bnl ORF Δ1-93 bps 
(R233G;R236G) 
pUbi-WgSP-EGFP-
rfA-Myc 
Site-directed mutagenesis 
using TKO21/22 
TKP34 bnl ORF Δ1-93 bps 
(R642G;R645G) 
pUbi-WgSP-EGFP-
rfA-Myc 
Site-directed mutagenesis 
using TKO29/30 
TKP35 bnl ORF Δ1-93 bps 
(R687G;R690G) 
pUbi-WgSP-EGFP-
rfA-Myc 
Site-directed mutagenesis 
using TKO31/32 
TKP36 
 
bnl ORF Δ1-93 bps 
(R164S;R233G; 
R236G) 
pENTR/D-TOPO-
bnlORF Δ1-93 bps 
Site-directed mutagenesis 
using TKO27/28 and then 
TKO21/22 
TKP37 
 
bnl ORF Δ1-93 bps 
(R164S;R233G; 
R236G) 
pUbi-WgSP-EGFP-
rfA-Myc 
LR recombination of TKO3 
with TKO36 
TKP38 
 
bnl ORF Δ1-93 bps 
(R642S;R645G; 
R687G;R690G) 
pUbi-WgSP-EGFP-
rfA-Myc 
Site-directed mutagenesis 
using TKO29/30 and then 
TKO31/32 
TKP39 bnl ORF Δ1-93 bps (with all 4 furin 
sites mutated) 
pENTR/D-TOPO-
bnlORF Δ1-93 bps 
Site-directed mutagenesis 
using TKO27/28, TKO21/22, 
TKO29/30 and TKO31/32 
TKP40 bnl ORF Δ1-93 bps 
(with all 4 furin 
sites mutated) 
pUbi-WgSP-EGFP-
rfA-Myc 
LR recombination of TKP3 
with TKP39 
TKP41 bnl ORF Δ1-93 bps pUASTattB-WgSP-
EGFP-rfA-Myc 
LR recombination of TKP1 
with TKP8 
TKP42 3x FLAG pUbi-rfA-EGFP Cloning via SpeI 
TKP43 WgSP pUbi-FLAG-rfA-EGFP PCR with TKO4/5, cloning via 
SpeI 
TKP44 WgSP-FLAG-rfA-
EGFP cassette 
pUASTattB Cloning of the cassette via 
XbaI 
TKP45 bnl ORF Δ1-93 bps pUASTattB-WgSP-
FLAG-rfA-EGFP 
LR recombination of TKP1 
with TKP44  
TKP46 bnl ORF Δ1-93 bps 
(with all 4 furin 
sites mutated) 
pUASTattB-WgSP-
FLAG-rfA-EGFP 
LR recombination of TKP39 
with TKP44 
TKP47 bnlN(bnl ORF 93-
711 bps) 
pUASTattB PCR with TKO36/38, cloning 
via BglII/XhoI  
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TKP48 bnlC(bnlORF 709-
2310 bps) 
pUASTattB-bnlN PCR with TKO41/34, cloning 
via XhoI/KpnI 
TKP49 egfp ORF pUASTattB-bnlN-
bnlC 
PCR with TKO39/40, cloning 
via XhoI 
TKP50 rfA cassette pUASTattB Subcloning via XbaI site 
TKP51 bnl ORF pUASTattB-rfA LR recombination of TKP6 
with TKP50 
TKP52 bnl ORF(R164S; 
R233G;R236G) 
pENTR/D-TOPO-
bnlORF 
Site-directed mutagenesis 
using TKO27/28 and then 
TKO21/22 
TKP53 bnl ORF with all 4 
furin sites mutated 
pENTR/D-TOPO-
bnlORF(R164S; 
R233G;R236G) 
Site-directed mutagenesis 
using TKO29/30 and then 
TKO31/32 
TKP54 
 
bnl ORF(R164S; 
R233G;R236G) 
pUASTattB-rfA LR recombination of TKP50 
with TKP52 
TKP55 bnl ORF with all 4 
furin sites mutated 
pUASTattB-rfA LR recombination of TKP50 
with TKP53 
TKP56 bnl SP sequence 
(1-93 bp of ORF) 
pUASTattB PCR with TKO36/37, cloning 
via BglII/XhoI 
TKP57 bnlSTV pUASTattB-bnlSP-
rfA 
PCR with TKO33/34, cloning 
via KpnI 
TKP58 bnlSTV-GGK pUASTattB-bnlSP-
rfA 
PCR with TKO33/35, cloning 
via KpnI 
TKP59 α1-PDX ORF pUASTattB Cloning via EcoRI and XhoI 
TKP60 btl ORF Δ1-66 bps pENTR/D-TOPO PCR with TKO6/7, TOPO 
cloning 
TKP61 3x FLAG pUbi-rfA Cloning via SpeI 
TKP62 WgSP pUbi-FLAG-rfA PCR with TKO4/5, cloning via 
SpeI 
TKP63 btl ORF Δ1-66 bps  pUbi-WgSP-FLAG-
rfA 
LR recombination of TKP60 
with TKP62 
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2.8 List of fly stocks generated for this work 
Stock 
number 
Genotype Description 
TKF1 y*w*;;P{w[+mC]UAST-WgSP-EGFP-bnlΔ1-31-
10xMyc}/TM3,Ser 
Transgene TKP41 
TKF2 y*w*;;P{w[+mC]UAST-WgSP-FLAG-bnlΔ1-31-
EGFP}/TM3,Ser 
Transgene TKP45  
TKF3 y*w*;;P{w[+mC]UAST-WgSP-FLAG-bnlΔ1-31 
MFS 1-4-EGFP}/TM3,Ser 
Transgene TKP46  
TKF4 y*w*;;P{w[+mC]UAST-bnl/TM3,Ser Transgene TKP51 
TKF5 y*w*;;P{w[+mC]UAST-bnlMFS1,2}/TM3,Ser Transgene TKP54  
TKF6 y*w*;;P{w[+mC]UAST-bnlMFS1-4}/TM3,Ser Transgene TKP55  
TKF7 y*w*;;P{w[+mC]UAST-bnlSTV}/TM3,Ser Transgene TKP57  
TKF8 y*w*;;P{w[+mC]UAST-bnlSTV-GGK}/TM3,Ser Transgene TKP58  
TKF9 y*w*;;P{w[+mC]UAST-α1-PDX}/TM3,Ser Transgene TKP59  
 w1118;Df(3R)Exel6202,P{w[+mC]=XP-
U}Exel6202/TM6B,P{ubx-lacZ},Hu 
Balanced line (Gerd 
Vorbrüggen) 
 ry506 P{PZ}Fur1rL205/TM6B,P{ubx-lacZ},Hu Balanced line (Gerd 
Vorbrüggen) 
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2.9 List of other fly stocks used 
Stock 
number 
Genotype Source 
8164 w1118 Bloomington 
109128 y1 w67c23; P{GAL4-btl.S}2 Kyoto Stock Center 
NP2211 w*;P{GawB}NP2211/ TM3, Sb1 Ser1 Kyoto Stock Center 
Gö1339 w*;P{w[+mC]=tubP-GAL4}/CyO Departmental stock 
1774 w*; P{GawB}69B Bloomington 
6384 ry506 P{PZ}bnl00857/TM3, Sb1 Bloomington 
7681 w1118;Df(3R)Exel6202,P{w[+mC]=XP-
U}Exel6202/TM6B, Tb1 
Bloomington 
10341 ry506 P{PZ}Fur1rL205/TM3, ryRK Sb1 Ser1 Bloomington 
 
 
2.10 List of primary antibodies 
Antibody Source Producer Epitope Dilution 
Anti-GFP rabbit Synaptic 
Systems 
EGFP 1:2000 (for 
Western blot) 
1:500 (for 
cytofluorescense) 
ab290 rabbit Abcam EGFP 1:1000 
Anti-Myc mouse Iowa-
Hybridoma Bank 
Myc tag 1:30 
Anti-FLAG M2 mouse Sigma Aldrich FLAG 1:5000 (for 
Western blot) 
1:1000 (for 
cytofluorescense) 
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2A12 mouse Iowa Hybridoma 
Bank 
Tracheal 
lument 
1:200 
β-galactosidase rabbit Cappel β-
galactosidase 
1:1000 
Anti-BnlN rabbit Gift from Mark 
Krasnow 
Bnl 1:100 
 
 
2.11 List of secondary antibodies 
Epitope Source Producer Label Dilution 
Mouse IgG goat Peirce HRP 1:2000 
Rabbit IgG goat Pierce HRP 1:2000 
Mouse IgG goat Molecular Probes Alexa 568 1:500 
Rabbit IgG goat Molecular Probes Alexa 488 1:500 
Mouse IgM goat Jackson 
ImmunoResearch 
Laboratories 
Biotinylated 1:400 
DIG sheep Roche Alkaline 
phosphatase 
1:2000 
Rabbit IgG goat Vector 
Laboratories 
Biotinylated 1:400 
Rabbit IgG donkey Jackson 
ImmunoResearch 
Laboratories 
Alkaline 
phophatase 
1:400 
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3 RESULTS 
3.1 Observation of Bnl cleavage  
3.1.1 Bnl protein is proteolytically cleaved in Drosophila embryonic cells 
Interactions between extracellular signaling molecules and the cellular surface 
play a key role in cell-to-cell communication within a multicellular organism during 
processes of development, tissue repair, homeostasis and immune response. Heparan 
sulphate proteoglycans (HSPGs) are exactly positioned in the place where this 
complex communication takes place – in the extracellular matrix (ECM) (reviewed in 
Häcker et al., 2005). HSPGs were implicated in different signaling events including 
Wingless/Wnt, transforming growth factor-β (TGF- β), Hedgehog (Hh) as well as 
fibroblast growth factor (FGF) signal-transduction pathways (Han et al., 2005; 
Belenkaya et al., 2004; Bellaiche et al., 1998; Freeman et al., 2008; Yan and Lin, 
2009). However, the mechanism and specificity of their action remain elusive. It was 
shown recently that one of Drosophila membrane bound HSPGs, Dally-like (Dlp) 
(Gallet et al., 2008) interacts with the Branchless (Bnl) protein, one of the three 
Drosophila FGF homologues, in vivo and modulates its activity in the embryonic 
tracheal system (Yan and Lin, 2007). Based on the experimental evidence, it was 
proposed that Dlp directly binds Bnl and facilitates its interaction with the FGF receptor 
Breathless (Btl). The aim of the current study is to analyze functional domains of the 
Bnl protein and investigate, how cell surface bound HSPGs modulate the Bnl/Btl 
signaling during tracheal system development.  
In order to establish a cell culture based assay to detect direct interactions of 
Drosophila cell surface HSPGs with extracellular Bnl, a tagged Bnl protein was 
overexpressed in Drosophila Kc cell culture. The construct for bnl expression was 
created employing the Gateway recombination cloning technology (Invitrogen) by 
recombining the bnl ORF without the N-terminal signal sequence (bnlΔ1-93 bp) into a 
destination vector with a constitutive ubiquitin promoter. The resulting construct 
contains the bnlΔ1-93 ORF fused with the wg signal sequence, EGFP ORF and a 57 bp 
linker sequence on the N-terminus and a 10x Myc tag, separated from the bnl 
sequence by a 61 bp linker on the C-terminus (Figure 13A). This construct was used 
for transient transfection in Drosophila embryonic cell culture. Kc cells overexpressing 
tagged Bnl protein and cell supernatants were harvested and efficiency of protein 
expression and secretion was estimated by Western blot analysis with both anti-GFP 
and anti-Myc antibodies. 
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Figure 13: EGFP-Bnl-Myc cleavage in Kc cells and supernatants. (A) A schematic drawing 
of the recombinant tagged Bnl expression construct. (B) A schematic drawing of the EGFP-Bnl-
Myc and Bnl FL-Myc proteins with two potential cleavage sites. (C) Western blot analysis of the 
overexpressed EGFP-Bnl-Myc and its cleavage products in cell extracts and cell supernatants. 
Arrows indicate the revealed Bnl protein. A schematic representation of the detected Bnl forms 
is shown between the Western blot panels.The cleaved off N-terminal domain is detected in both 
cell extract and cell supernatant, whereas the full length protein can be only revealed in cell 
extract with the anti-GFP antibody. (D) Western blot analysis of overexpressed EGFP-Bnl-Myc 
and Bnl FL-Myc. Full length proteins as well as the products of the N- and C-terminal cleavage 
are detected with the anti-Myc antibody both in cell extracts and cell supernatants.  
 
Surprisingly, not only the full length tagged Bnl protein (~200 kDa, further also 
referred to as EGFP-Bnl-Myc) was detected in cell supernatants as well as in cell 
extracts. Additionally, a 60 kDa N-terminal peptide was revealed with the anti-GFP 
antibody mostly in cell supernatant and two C-terminal peptides of 130 kDa and 50 
kDa were detected with the anti-Myc antibody in both cell extract and supernatant 
(Figure 13B, C and D). This finding indicated that the EGFP-Bnl-Myc protein was 
cleaved into three parts in Kc cells. Moreover, all three cleavage products could be 
detected in cell extracts, pointing out that the cleavage occured intracellularly. Further 
experiments described in this manuscript were carried out to explore the unusual 
behavior of the Bnl ligand. 
In order to exclude that the addition of ectopic wingless signaling peptide 
(wgSP) and the EGFP sequence could be responsible for this cleavage, the Bnl protein 
carrying its own signal sequence and only tagged at the carboxy-terminus with 10x 
Myc tag was expressed in cell culture and analyzed by Western blot. Similar to the 
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previous observation, two peptides of 130 kDa and 50 kDa were detected with the 
anti-Myc antibody (Figure 13D), proving that also the wild type Bnl protein is cleaved 
in Kc cells and the addition of wgSP and EGFP does not have any impact on EGFP-Bnl-
Myc cleavage. 
 An additional experiment was performed to exclude the possibility that 
cleavage of the recombinant Bnl protein occurs extracellularly as a result of non-
specific proteolytic activity. If the cleavage would occur after the secretion process, 
the peptides would have to stick to the cellular surface, as the cleaved peptides could 
be detected within the cell extracts (Figure 13). To inhibit extracellular protease 
activity, a protease inhibitor cocktail (Complete Mini Protease Inhibitor, Roche) was 
added to the medium of Kc cells transiently transfected with the EGFP-Bnl-Myc 
construct and cell supernatants were analyzed by Western blot. 
 
 
 
 
 
 
 
Figure 14: Intracellular cleavage of EGFP-Bnl-Myc in the presence of protease 
inhibitors. Western blot analysis of EGFP-Bnl-Myc expression (A) and secretion (B) with or 
without the addition of the protease inhibitor to conditioned medium. Arrows indicate the 
revealed Bnl protein. A schematic drawing of the detected protein forms is shown on the right. 
The cleaved off N-terminal domain of Bnl is detected in both cell extract and cell supernatant, 
whereas the full length protein can be only revealed in cell extract with the anti-GFP antibody.  
 
The result represented in Figure 14 shows that the product of EGFP-Bnl-Myc amino-
terminal cleavage is still present in cell extract as well as in supernatant in the 
presence of protease inhibitors, excluding Bnl unspecific cleavage outside the cells.  
Taken together, the results obtained clearly show that the Bnl protein is 
cleaved intracellularly into three peptides by an unknown protease in Drosophila cell 
culture. Since the Bnl molecule carries unusually large domains flanking a conserved 
FGF domain which are not found in all known FGF homologues from vertebrates 
(Introduction 1.2.3 and Sutherland et al., 1996) and there are several reports that 
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some of vertebrate FGFs undergo proteolytic processing (Bellosta et al., 1993; Antoine 
et al., 2000; Fukumoto et al., 2005), the results correspond to a model in which the 
Bnl protein cleavage observed is carried out by a specific protease. 
 
3.1.2 Bnl undergoes proteolytic cleavage in Drosophila embryos 
In order to verify whether Bnl/FGF cleavage occurs not only in Drosophila cell 
culture but also in a living organism, the UAS/GAL4 system (Brand and Perrimon, 
1993) was utilized to induce tissue specific expression of EGFP-Bnl-Myc protein in 
Drosophila embryos. Flies carrying homozygous btlGAL4 driver, activating expression 
of UAS transgenes in embryonic tracheal cells, were crossed to UAS-EGFP-Bnl-Myc 
transgenic flies. Embryo extracts of F1 progeny were subjected to Western blot 
analysis. The result shown in Figure 15 clearly indicates that the EGFP-Bnl-Myc protein 
is proteolytically cleaved in vivo as well. It was possible to visualize a 60 kDa cleaved 
N- terminal peptide with the anti-GFP antibody (Figure 15A) and the anti-Myc antibody 
revealed in addition to the full length EGFP-Bnl-Myc protein a 130 kDa cleaved variant 
as a result of the amino-terminal cleavage and 55 kDa cleaved carboxy-terminal 
peptide (Figure 15B). A minor increase in molecular mass of the C-terminal cleavage 
product can be explained by a higher degree of post-translational protein modifications 
taking place in Drosophila embryos compared to cell culture conditions. 
 
 
 
 
 
 
 
 
 
Figure 15: Cleavage of the EGFP-Bnl-Myc protein in Drosophila embryos. Western blot 
analysis of the embryos expressing the recombinant Bnl protein in the tracheal cells. Full length 
protein and the cleavage products are detected with the anti-GFP (A) and anti-Myc antibodies 
(B). Arrows and a schematic drawing between the panels show the revealed forms of Bnl. 
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Taken together, all results shown strongly indicate that Bnl is proteolytically 
cleaved within the secreting cells both in embryonic cell culture and in Drosophila 
embryos resulting in three cleavage products: a N-terminal peptide (approximately 30 
kDa when untagged), middle part carrying an intact or truncated FGF domain (~34-37 
kDa) and a small C-terminal peptide (~22 kDa when untagged). However, without 
precise identification of the cleavage sites it is not yet clear whether Bnl cleavage 
represents a propeptide activation step releasing the conserved FGF domain or, in 
opposite, it may serve as a mechanism of the growth factor inactivation if the 
cleavage occurs within the FGF domain. 
 
3.1.3 Drosophila Bnl is N-glycosylated 
Whereas the anti-Myc antibody could reveal the full length EGFP-Bnl-Myc 
protein in cell extracts as well as in supernatants, the anti-GFP antibody fails to detect 
the secreted full length protein (Figure 13). This could be caused by protein 
modifications which are masking the antibody epitope. It is known, that mammalian 
FGFs show a varying degree of glycosylation that is important for their stability and 
secretion and in some cases for the activity of growth factors (Bates et al., 1991; 
Asada et al., 1999). 
N-glycosylation is the most frequent post-translational modification for secreted 
eukaryotic proteins. It occurs at asparagin residues of the polypeptide chain (Walsh et 
al., 2005). To analyze whether EGFP-Bnl-Myc carries post-translational N-
glycosylation, supernatant of overexpressing Kc cells was treated with peptide-N-
glycosydase F (PNGase F) to remove N-linked sugar moieties from the polypeptide 
chain. Deglycosylated and control cell supernatant samples were subjected to Western 
blot analysis. As shown in Figure 16, treatment with PNGase F results in a clear 
reduction of the apparent molecular weight of the cleaved amino-terminal protein 
portion. Furthermore, after glycosidase treatment the second GFP-positive band of 
150 kDa, corresponding to the C-terminally cleaved Bnl can be detected. 
This result shows that, similar to mammalian FGFs, Bnl is N-glycosylated and 
this modification is at least partially responsible for the dramatically increased 
apparent molecular weight of the Bnl full length protein observed on SDS PAGE. 
Furthermore, the N-glycosylation seems to be the cause for the impaired binding of 
the anti-GFP antibody to high molecular weight Bnl forms. However, since the 
treatment with PNGase F did not help to reveal the full length Bnl protein, further 
Western blot experiments were carried out using the anti-Myc antibody for the tagged 
protein detection.  
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Figure 16: Deglycosylation of EGFP-Bnl-Myc. Western blot analysis of the EGFP-Bnl-Myc 
supernatants with or without treatment with PNGase F enzyme. The products of the N-terminal 
Bnl cleavage are detected with the anti-GFP antibody. A schematic representation of the 
revealed Bnl forms is shown on the right. N-linked glycosylation of Bnl increases its apparent 
molecular weight and partially masks the anti-GFP antibody epitope. 
 
3.1.4 Anterograde trafficking is required for Bnl cleavage 
The majority of secreted eukaryotic proteins containing an amino-terminal 
signal sequence peptide utilizes the classical intracellular secretory pathway, which 
leads them from the endoplasmic reticulum (ER) to the Golgi apparatus and further in 
secretory vesicles to the plasma membrane and eventually to the extracellular 
environment (Reynaud and Simpson, 2002; Abrahamsen and Stenmark, 2010). 
According to the available data, a proteolytic cleavage of cargo proteins may occur in 
each of these transportation steps (Boddey et al., 2010; Wallis et al., 2003). 
Moreover, it was previously described that some of mammalian FGFs utilize an 
unconventional secretory pathway for their secretion (Zehe et al., 2006; Nickel and 
Rabouille, 2009). In order to investigate whether the ER to Golgi transport is essential 
for EGFP-Bnl-Myc cleavage and secretion, anterograde trafficking was blocked in Kc 
cells using siRNA knockdown approach. Two different dsRNAs containing the sec23 
sequence were co-transfected with EGFP-Bnl-Myc in Kc cells. Sec 23 is essential for 
the coat-protein complex II (COPII) vesicle assembly (reviewed in Fromme et al., 
2008) and depletion of this protein leads to the blockage of anterograde vesicle 
trafficking. Under these conditions all secreted proteins synthesized by the cell are 
retained in the ER. Cell extracts and supernatants from Sec23 dsRNA treated or 
control Kc cells were harvested and analyzed by Western blot. The result shows that 
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inhibition of anterograde vesicle trafficking completely blocks both the protein 
cleavage and secretion (Figure 17). 
This indicates that the EGFP-Bnl-Myc protein utilizes the classical secretory 
pathway within the cell and has to enter the Golgi apparatus for its secretion. 
Furthermore, dsRNA treatment inhibits Bnl cleavage as well, suggesting that the 
protease activity is localized and processing occurs downstream of the ER, either in 
the Golgi or even further downstream. 
 
 
 
 
 
 
Figure 17: Inhibition of anterograde trafficking in Kc cells. Western blot analysis of 
Drosophila Kc cell extracts (A) and supernatants (B), treated with the two different dsRNAs 
(#47 and #48) against Sec23 and transiently expressing the EGFP-Bnl-Myc protein. Bnl protein 
is detected with the anti-Myc antibody. A schematic drawing of the revealed protein forms is 
shown between the panels. Blockage of anterograde protein trafficking prevents Bnl cleavage 
and secretion. 
 
 
3.2 Identification of Bnl cleavage sites and the cleaving protease 
3.2.1 Amino-terminal Bnl cleavage occurs upstream of the FGF domain 
 The observed Bnl cleavage may serve two different purposes. It can either 
represent the process of proteolytic protein activation releasing its biologically 
functional central FGF domain, or alternatively, the cleavage can reveal the 
mechanism of regulation of signaling activity and contribute to the growth factor 
degradation and turn over. It is reasonable to assume that activating Bnl cleavage has 
to preserve the integrity of the conserved FGF domain. Conversely, an inactivating 
cleavage would preferentially occur within this domain. According to molecular masses 
of the cleavage products observed, Bnl N-terminal cleavage takes place directly 
upstream or within the FGF domain. In order to identify the location of the Bnl N-
terminal cleavage site, three C-terminally truncated Bnl variants were generated.  
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Figure 18: Analysis of the Bnl truncated variants. Western blot analysis of cell 
supernatants from Kc cells overexpressing truncated variants of Bnl. Detection of tagged 
proteins is performed with the anti-GFP antibody. A schematic representation of Bnl protein 
variants is shown on the right. Location of the N-terminal cleavage site is marked with red 
arrows. N-terminal cleavage of Bnl occurs upstream of the Bnl FGF domain. 
 
The first construct represents the EGFP ORF fused to the Bnl N-terminal sequence up 
to the FGF domain (EGFP-Bnl N), the second construct contains the EGFP sequence, 
the Bnl N-teminal sequence and the full length FGF domain (EGFP-Bnl N-FGFdom.), 
the third variant has an additional C-terminal Myc tag (EGFP-Bnl N-FGFdom-Myc). The 
three truncated variants were transiently expressed in Drosophila cell culture and 
secreted fusion proteins were visualized by Western blot. As shown in Figure 18, an 
amino-terminal 60 kDa peptide was detected in all protein variants tested, proving 
that the N-terminal cleavage occurs upstream of the conserved FGF domain of Bnl. 
Consequently, this experiment supports the idea that Bnl cleavage represents the 
mechanism of growth factor maturation. 
 
3.2.2 N-terminal Bnl cleavage occurs between S229 and N234 
 The three deletion constructs allowed to narrow down the localization of the Bnl 
amino-terminal cleavage site to the region of the 28 amino acids adjacent to the FGF 
domain. In order to identify the cleavage site within this area, an additional series of 
N-terminally truncated Bnl variants were generated (Figure 19A). To avoid undesirable 
background from non-specific EGFP cleavage and to visualize even minor differences 
in molecular masses of the cleaved fragments, a small 3x FLAG-tag was used to mark 
N-terminal parts of the constructs. The resulting Bnl variants were expressed in cell 
culture and supernatants were subjected to Western blot analysis. 
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Figure 19: Bnl N-terminal cleavage occurs between S229 and N234. (A) A schematic 
representation of the Bnl N-terminal cleavage region and the N-teminal truncation constructs 
showed in different colors. (B) Western blot analysis of cell supernatants from Kc cells 
overexpressing Bnl truncated variants. The tagged proteins are detected with the anti-FLAG 
antibody. A schematic drawing of the revealed protein forms is on the right. Numbers and 
colored boxes mark the lanes corresponding to the truncated Bnl variants depicted in (A). Lower 
part of the blot shows low molecular weight peptides with a longer exposition of the same 
membrane. 
 
Protein gel electrophoresis was performed using a 15% Tricine gel to achieve an 
appropriate separation of small amino-terminal peptides. The detection of Bnl variants 
was carried out with the anti-FLAG antibody. As represented on Figure 19B, samples 
1, 2 and 3 contain the small cleaved off FLAG-positive bands (11-15 kDa) showing the 
expected molecular weight differences corresponding to the length of the constructs. 
In contrast, samples 4, 5 and 6 reveal the high molecular weight bands of 
approximately 85 kDa, corresponding to the uncleaved fusion protein but no clear 
bands in the range of the cleaved FLAG-tag. According to the output of this 
experiment, it is possible to conclude, that the N-terminal cleavage takes place 
between S229 and N234 of the Bnl protein sequence. However, it is necessary to take 
into account that in the represented experimental setup, the FLAG-tag localizes in 
close proximity to the cleavage site and could interfere with an efficient cleavage 
process. Moreover, the cleavage site could be destroyed due to truncation. Therefore 
further approaches were applied to identify the precise position of the N-teminal Bnl 
cleavage site. 
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3.2.3 Bnl is cleaved between R236 and S237 by a furin protease 
 In order to precisely identify the N-terminal cleavage site, in silico analysis of 
the Bnl protein sequence was performed to screen for a potential protease recognition 
site in the region of interest. This approach revealed the presence of a furin protease 
recognition motif (–R–N–E–R–) between D232 and S237 of the Bnl sequence. 
Moreover, three more potential furin recognition sites were identified in the Bnl protein 
sequence: one was found N-terminally of the already mentioned furin site, and two – 
in the C-terminus beyond the conservative FGF domain (Figure 20A). Furin is a highly 
conserved subtilisine-like proprotein convertase (SPC) found in a broad range of 
organisms from yeast to humans. As it was shown previously, furin protease resides in 
the trans-Golgi network (TGN) and represents the major processing enzyme of the 
cellular secretory pathway (Molloy et al., 1994; Steiner, 1998). Furins are highly 
specific endoproteases that have a recognition sequence –R–X–K/R–R↓– (where X is 
any amino acid and the arrow represents the cleavage point). However it was shown 
in many cases that these proteases can also effectively cleave the so-called minimal 
furin recognition motif –R–X–X–R↓– (Thomas, 2002), that was actually detected in the 
Bnl sequence.  
 
 
 
 
 
 
 
 
 
Figure 20: Bnl N-terminal cleavage is performed by a furin protease. (A) A chematic 
drawing of the Bnl protein with potential furin cleavage sites identified in silico. Furin site 
confirmed by the mutagenesis is shown by the red arrow. Other three furin motives are shown 
by black arrows (B) Western blot analysis of cell supernatants from Kc cells overexpressing the 
N-truncated variants of Bnl with Arg to Gly substitutions within the furin recognition site. 
Tagged proteins are detected with the anti-GFP antibody. A schematic drawing of the revealed 
Bnl protein forms is shown next to the Western blot panel. Location of the cleavage site is 
indicated by the red arrow. Site-directed mutagenesis of the identified furin recognition motif 
prevents processing of truncated Bnl. 
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To examine whether furin subtilisin-like proteases are indeed involved in Bnl 
cleavage, a site-directed mutagenesis approach was employed in order to disrupt the 
N-terminal furin cleavage site in the recombinant Bnl protein. Two EGFP- and Myc-
tagged mutated Bnl variants were designed. Each of them carries a single Arg to Gly 
substitution (either R233G or R236G) in the mapped –R–X–X–R↓– Bnl recognition 
motif. Moreover, both protein variants are N-terminaly truncated (BnlΔ1-214) in order 
to prevent Bnl cleavage via an additional N-terminal furin recognition site. The 
constructs were expressed in cell culture and secreted proteins were detected in the 
supernatants by Western blot analysis. The result represented in Figure 20B shows, 
that the 36 kDa EGFP-positive peptide cleaved off from the non-mutated protein 
variant is absent when either of the two arginines of the furin recognition site is 
mutated. 
This data clearly shows that Bnl is processed within its N-terminus between 
R236 and S237 by a Drosophila furin proprotein convertase. However, since three 
additional potential furin protease recognition sequences were identified within the Bnl 
protein, it is still to be explored if all of these sites contribute to the Bnl cleavage and 
if the observed C-terminal processing requires furin proprotein convertase activity. 
 
3.2.4 Alpha1-PDX inhibitor blocks N- and C-terminal Bnl processing 
 Another widely used approach to identify proteases and their targets is to 
employ a specific protease inhibitor. Alpha1-antitrypsin variant Portland (α1-PDX) – is 
a potent and selective inhibitor of the SPC family of proteases. It was bioengineered 
from a mammalian α1-antitrypsin protease variant and contains a minimal furin 
consensus motif in its reactive loop. When expressed in cell culture, this protein 
effectively inhibits proprotein convertase related proteolytic activity (Benjannet et al., 
1997; Jean et al., 1998). 
 In order to examine whether furin protease is indeed implicated in both N- and 
C-terminal Bnl cleavage, an α1-PDX coding sequence (a gift from G. Thomas) was co-
expressed together with EGFP-Bnl-Myc in cell culture under control of a constitutive 
actin5C promoter. Resulting cell supernatants were analyzed by Western blot using 
the anti-Myc antibody. As represented in Figure 21, both the 50 kDa and the 130 kDa 
Bnl forms corresponding to the C- and N-terminal cleavage are absent in the presence 
of the α1-PDX inhibitor. In contrast, the 200 kDa full length form of Bnl becomes more 
apparent. This independent approach shows that the specific SPC inhibitor α1-PDX is 
able to effectively block Bnl cleavage. Thus, our data strongly indicates, that 
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Drosophila furin proprotein convertase is involved in both amino- and carboxy-
terminal Bnl processing. 
 
 
 
 
 
 
 
 
 
 
Figure 21: Alpha1-PDX inhibits the Bnl cleavage in cell culture. Western blot analysis of 
cell supernatants from Kc cells co-expressing EGFP-Bnl-Myc and α1-PDX inhibitor of SPC 
proteases. Tagged proteins are revealed with the anti-Myc antibody. A schematic representation 
of the detected Bnl forms is on the left. The inhibitor blocks both N- and C-terminal protein 
cleavage, suggesting that furin is involved in N- and C-terminal processing of Bnl.  
 
3.2.5 Drosophila Furin1 activity is necessary for Bnl cleavage in cell culture 
According to the available data and the genome annotation, there are two 
genes encoding furin proteases in Drosophila melanogaster (Roebroek et al., 1991; 
Roebroek et al., 1992; Flybase data), which are designated as dfur1 and dfur2. Like 
their homologues from other organisms, Drosophila furins are involved in the 
processing of secreted signaling molecules. For example, it was shown previously that 
both Dfur1 and Dfur2 proteins participate in the proteolytic processing of the 
Drosophila TGF-β homolog Decapentaplegic (Dpp) (Panganiban et al., 1990). 
However, they reveal different affinity towards the three furin recognition motives 
found in this protein. (Künnapuu et al., 2009). Since each of these two proteases is 
present in Drosophila Kc cells, it was interesting to investigate, whether both of them 
are required for Bnl processing, as it was shown for Dpp. 
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Figure 22: Drosophila furin 1 is responsible for Bnl cleavage in cell culture. (A) Western 
blot analysis of cell supernatants from Kc cells overexpressing EGFP-Bnl-Myc and treated with 
dsRNAs inhibiting either the Dfur1 or Dfur2 expression. Tagged Bnl is detected with the anti-Myc 
antibody. A schematic drawing of the revealed protein forms is shown on the left. Inhibition of 
Dfur1 activity is able to prevent Bnl processing. (B) Semi-quantitative PCR analysis for 
evaluation of dsRNAs silencing efficiency. On the left: quantitation of relative intensity of the gel 
bands in percents. Silencing efficiency for both Dfur1 and Dfur2 expression is ~85%. 
 
In order to specifically inhibit the expression of one or the other of Drosophila 
furins, dsRNAs containing 150 bp of either dfur1 or dfur2 sequence were co-expressed 
with the EGFP-Bnl-Myc construct in Kc cell culture. Supernatants from dsRNA treated 
or control cells were subjected to Western blot analysis. As represented in Figure 22A, 
samples treated with dsRNA against Dfur1 show dramatically reduced Bnl cleavage in 
comparison with the control, whereas no significant difference was detected in the 
supernatants from the cells with the silenced Dfur2 expression, although both 
proteases show relatively similar RNA level (Figure 22B). The efficiency of dsRNA 
silencing was estimated by semi-quantitative PCR using a cDNA library prepared from 
Dfur1 or Dfur2 dsRNA treated Kc cells. According to quantitative analysis of DNA band 
intensity, it was possible to decrease the expression rate of furins by more than 85% 
(Figure 22B). 
Thus, this experiment clearly shows that only Dfurin 1 is required for Bnl 
cleavage. Our data also indicates that the two Drosophila furin proteases have 
different specificity towards recognition motives and their functions are not redundant 
in the cell, consistently with the previous report of Künnapuu et al., 2009. 
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3.2.6 Bnl cleavage sites are conserved in FGF homologues from other Drosophila 
species 
 According to performed computed analysis, there are four furin consensus 
motives in the Bnl protein sequence. Two of them are found upstream of the 
conserved FGF domain in the amino-terminal region, whereas the other two are 
positioned within the C-terminal part of the protein. For convenience, all furin 
recognition sites were designated with numbers from 1 to 4 (Figure 23). 
 
 
 
Figure 23: Furin recognition motives identified in Bnl protein. A schematic representation 
of the Bnl protein with furin consensus motives marked with red lines and arrows. Bnl containes 
two N-terminal and two C-terminal furin cleavage sites. 
 
Furin recognition site1 (FS1) is located between S160 and H168 of the Bnl protein 
sequence. It is the most distal N-terminal motif and is separated from FS2 by 65 
amino acids, containing stretches of repeated residues (groups of serine, glutamine 
and histidine), of unknown purpose. Interestingly, FS1 consists of two minimal furin 
recognition motives (–R–X–X–R–) fused together and building double furin site –R–T–
E–R–S–I–R–. However, it is not known whether such duplication of the protease 
recognition motif leads to more efficient cleavage of the site. 
The amino-terminal Bnl recognition site FS2 that was identified first (Results 
3.2.3) is located between D232 and S237 and represents a minimal furin recognition 
motif (–R–N–E–R–). The site is only six amino acids upstream of the beginning of the 
conserved FGF domain. FS3 is positioned far downstream of the FGF domain and 
occupies residues K641 to K646. Similar to FS2, it represents a minimal furin 
consensus motif (Figure 23). The most C-terminally localized furin site 4 is separated 
from FS3 by 38 amino acids and is located between D683 and M691. This recognition 
motif (–R–V–E–R–N–V–R–) is duplicated as well as furin site 1. Thus, the Bnl protein 
has two double minimal furin motives located distally and two single minimal sites 
located proximally to the conserved FGF domain. Such an extra duplication of the 
motives  and a symmetric disposition of furin recognition sites within the Bnl protein 
sequence has to be based on certain cellular (and/or organismic) needs and seems to 
represent a mechanism for the reliable FGF cleavage in the secreting cells. 
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 In order to check whether similar furin cleavage sites can be found in FGF 
homologues from other Drosophila species, a protein sequence alignment of Bnl was 
performed. An on-line service tool Blastp 2.2.18 was employed for this purpose 
(Altschul et al., 1997). The result of the alignment is summarized in Table 1. 
 
 
 
 
 
 
Table 1: Conservation of Bnl furin cleavage sites within Drosophilidae family. Alignment 
of Bnl furin recognition motives with those of the FGF homologues from other Drosophila 
species. FS1, FS2 and FS4 are highly conserved amon Bnl homologues, whereas FS3 shows 
sequence variability and is absent in Bnl homologue from D.mojavensis. 
 
Interestingly, all four furin recognition motives similar to Bnl cleavage sites were found 
in 9 out of 11 tested FGF homologues from different Drosophila species, despite a 
diverse protein length and organization. Another homolog from D. mojavensis contains 
only 3 of 4 found furin motives whereby FS3 is missing. Surprisingly, there was no Bnl 
homologous protein sequence found in D. grimshavi. 
Taken together, the alignment data indicates, that Bnl cleavage sites are highly 
conserved among Drosophila species despite the difference in the length of the 
homologues. It is still to be explored, whether each of them have distinct relevance for 
the growth factor processing, secretion and functionality. 
 
3.2.7 Mutagenesis of Bnl cleavage sites in Drosophila cell culture 
In order to investigate the contribution of each of the identified furin cleavage 
sites for Bnl cleavage, a site-directed mutagenesis approach was employed to mutate 
sequentially each of the four recognition sites. One or two cleavage sites were 
mutated at the same time on either the N- or C-termini of the Bnl protein. A list of the 
amino acid substitutions is represented in Table 2. In the duplicated FS1 the central 
arginine was substituted to serine in order to destroy both recognition sequences at 
the same time (R164S). FS2 has both consensus arginine residues mutated to glycine 
(R233G and R236G). Also both arginines are mutated in the minimal furin recognition 
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motif number 3 (R642G and R645G). The duplicated FS4 contains two amino acid 
substitutions affecting the second and third arginines of the cleavage site (R687G and 
R690G).  
 
 
 
 
 
 
Table 2: Amino acid substitutions in furin consensus motives of Bnl. Sequence of Bnl 
furin recognition motives and amino acid substitutions introduced by site-directed mutagenesis 
(furin consensus motives are marked in red; amino acid substitutions are in bold). 
 
In order to investigate the function of each recognition site alone and in 
combination, seven mutated Bnl variants were generated. The constructs were 
supplied with amino-terminal EGFP and carboxy-terminal Myc tags for effective 
detection of the modified proteins and their cleavage products. The variants were 
designated with the letters MFS (for “mutated furin site”) and the numbers 
corresponding to the mutated furin site number. The following MFS combination 
constructs were generated: EGFP-Bnl MFS 1-Myc; EGFP-Bnl MFS 2-Myc; EGFP-Bnl MFS 
3-Myc; EGFP-Bnl MFS 4-Myc; EGFP-Bnl MFS 1,2-Myc (both N-terminal sites are 
mutated); EGFP-Bnl MFS 3,4-Myc (both C-terminal sites are mutated) and EGFP-Bnl 
MFS 1-4-Myc (all furin sites are mutated). The above-listed Bnl variants including non-
mutated EGFP-Bnl-Myc as a control were expressed in Kc cell culture and supernatants 
of these cells were subjected to Western blot analysis using both anti-GFP and anti-
Myc antibodies.  
The output of the experiment is represented in Figure 24. It shows that in the 
FS1 mutated variant the 60 kDa GFP-positive band corresponding to the amino-
terminal cleavage vanishes, whereas another band of 75 kDa appears, indicating that 
under these circumstances the amino-terminal Bnl cleavage can occur only via the 
second furin site. The 75 kDa GFP-positive peptide was previously detected on some 
of the blots. This band was left unattended since it was considered to be a background 
(Figures 13C). It is possible now to identify it as a product of the furin site (FS2) 
cleavage (Figure 24B). The third lane of the same figure shows that mutation of FS2 
leads to the amino-teminal Bnl cleavage using non-mutated FS1, resulting in the 
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appearance of the usual 60 kDa band. However, when both amino-terminal furin 
consensus sequences were mutated, neither 75 kDa nor 60 kDa GFP-positive bands 
were detected, suggesting that no amino-terminal Bnl cleavage could occur in the 
absence of valid furin recognition sites. 
A different situation was observed when the third and the fourth Bnl cleavage 
sites were mutated. The mutation of FS3 did not result in a difference in the masses of 
the cleaved C-terminal fragments (Figure 24C), whereas the mutation of the fourth 
furin recognition motif inhibited Bnl carboxy-terminal cleavage completely. The same 
result was observed when both C-terminal sites were mutated. This data strongly 
suggests that although FS3 represents a consensus furin recognition motif, it seems 
not to be cleaved by a furin protease in Drosophila cell culture. Eventually, the Bnl 
variant with all four furin sites mutated did not show any apparent cleavage (Figure 
24C), proving that the identified furin recognition motives are responsible for the Bnl 
processing. 
 
 
 
 
 
 
 
 
 
Figure 24: Site-directed mutagenesis of furin cleavage sites. (A) A schematic 
representation of furin cleavage sites localization in the Bnl protein. (B) Western blot analysis of 
supernatants from cells expressing the EGFP-Bnl-Myc constructs with mutated N-terminal 
cleavage sites. Bnl N-terminal domain is detected with the anti-GFP antibody. A schematic 
drawing of the revealed Bnl forms is shown between the panels. Only the mutagenesis of both 
N-terminal furin sites prevents the N-terminal protein processing. (C) Western blot analysis of 
supernatants from cells expressing the EGFP-Bnl-Myc constructs with mutated N- and C-
terminal cleavage sites. Tagged protein forms are detected with the anti-Myc antibody. Site-
directed mutagenesis of the FS4 alone blocks Bnl C-terminal cleavage. Mutagenesis of all four 
recognition motives prevents Bnl processing from both termini. 
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According to the represented data, the four furin consensus motives identified 
within the Bnl protein have a differential impact on its cleavage. Both the first and the 
second furin cleavage sites located on the amino-terminus are clearly utilized for the 
Bnl cleavage, since the mutagenesis of either site leads to the protein processing 
using the residual cleavage sequence. When both N-terminal cleavage sites are 
preserved, the FS1 is utilized for the cleavage as revealed by the EGFP tagged N-
terminal protein of 60 kDa. However, since FS2 is cleaved as well as shown by the FS1 
mutation, it is not clear if actually both recognition sites are used in Bnl. Regarding the 
carboxy-terminal cleavage, the FS4 site is clearly processed, whereas the mutation of 
the FS3 site had no effect, indicating that FS4 is the only used C-terminal furin 
cleavage site. Although it cannot be excluded, that FS3 might only be used if both C-
terminal recognition sites are present. 
 
3.2.8 Mutagenesis of Bnl cleavage sites in Drosophila embryos 
 To confirm the observed cleavage of Bnl by furin proteases in vivo, the effect of 
the site-directed mutagenesis of all furin cleavage sites within Bnl was investigated in 
Drosophila embryos. In order to analyze this, a transgenic fly line was generated that 
allowed the expression of the mutated Bnl protein using the GAL4/UAS system (Brand 
and Perrimon 1993). The Bnl variant containing wild type furin cleavage sites was 
compared with Bnl that carries the earlier described amino acid substitutions impairing 
all four furin recognition motives. Both constructs contain the N-teminal FLAG- and the 
C-terminal EGFP-tags for the detection of ectopically expressed Bnl proteins. The two 
transgenic fly lines, carrying either of the constructs, were crossed to the tubGAL4 
line, inducing strong ubiquitous transgene expression. Embryos of F1 progeny were 
harvested and subjected to Western blot analysis and the expressed protein variants 
were detected with the anti-FLAG antibody. 
The result of the experiment, shown in Figure 25, clearly shows, that the small 
FLAG-positive 28 kDa peptide, corresponding to amino-terminal Bnl cleavage, is not 
present in the protein sample in which furin recognition sites were mutated. 
Furthermore a band, representing the full length 200 kDa protein becomes slightly 
more intensive, indicating that the mutation of the furin recognition sites inhibits Bnl 
cleavage in vivo as well. 
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Figure 25: The effect of site-directed mutagenesis of Bnl furin sites in Drosophila 
embryos. Western blot analysis of the embryos expressing FLAG-Bnl-EGFP with the wild type or 
mutated furin recognition motives. Bnl protein is visualized with anti-FLAG antibody. Arrows 
indicate the cleaved and intact protein forms. A schematic drawing of the detected Bnl is shown 
on the right. Site-directed mutagenesis of all furin sites prevents Bnl processing in Drosophila 
embryos. 
Thus, the represented data strongly suggests that Bnl is proteolytically 
processed by a furin proprotein convertase in both Drosophila cells and embryos. 
Furthermore, the specific cleavage can be inhibited by the site-directed mutagenesis 
of the furin recognition motives. However, it is not yet understood, whether the 
correct processing of Bnl protein within the secreting cells is relevant for its biological 
activity. The experiments described below were carried out in order to clarify this 
issue. 
 
3.3 Relevance of Bnl processing for its biological function 
3.3.1 Bnl with mutated furin recognition sites is able to bind Btl receptor in cell culture  
 A basic biological function of all known fibroblast growth factors is their ability 
to bind FGFRs and cause their dimerization that represents the first step of receptor 
tyrosine kinase signaling (Eswarakumar et al., 2005; Polanska et al., 2009). It is also 
known that Bnl regulates FGF signaling by direct interaction with its receptor 
Breathless (Btl) (Sutherland et al., 1996). Therefore, it was interesting to verify 
whether the Bnl variant with impaired furin cleavage sites would show a specific 
binding to its receptor Btl. A cell culture based assay was employed to investigate the 
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direct binding of the secreted Bnl variants to the cell-surface localized Btl receptor. 
Drosophila Kc cells expressing FLAG-Btl (a FLAG-tag was introduced N-terminally of 
breathless ORF) were incubated with conditioned medium containing either tagged 
wild type Bnl or non-cleavable Bnl protein carrying mutated furin sites (Material and 
methods 2.2.4). In order to detect the conserved FGF domain of the cleavable Bnl 
variant, a full length EGFP sequence was introduced directly downstream of the second 
amino-terminal Bnl furin site (FS2) (Figure 26A). EGFP- and Myc-tagged construct 
containing the described amino acid substitutions impairing all four furin recognition 
motives was used for expression of the non-cleavable Bnl variant, designated as 
EGFP-BnlMFS1-4-Myc (Figure 26B). After incubation of the supernatants containing 
mutated and non-mutated Bnl with FLAG-Btl-expressing cells, the latter were fixed 
and stained with anti-FLAG and anti-GFP antibodies to visualize the binding partners 
on the cellular surface. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 26: Non-cleavable Bnl specifically binds the Btl receptor in Drosophila cells. 
Schematic representation of the cleavable BnlN-EGFP-BnlC (A) and the non-cleavable EGFP-
BnlMFS1-4-Myc (B) Bnl variants (FS – furin sites; MFS – mutated furin sites). Binding of the 
cleavable Bnl (C–C’’’), the non-cleavable Bnl (D–D’’’) and mock control (E–E’’’) to FLAG-Btl in 
cell culture (C, D, E – FLAG-Btl expression detected with the anti-FLAG antibody; C‘, D’, E’ – 
bound Bnl protein detected with the anti-GFP antibody; C’’, D’’, E’’ – overlay of the FLAG and 
GFP channels; C’’’, D’’’, E’’’ – transmitted light image). 
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The cells were further subjected to the laser scanning confocal microscopy. As shown 
on Figure 26C–C’’’, the GFP-marked FGF domain of the cleavable Bnl variant 
apparently co-localizes with the FLAG-Btl receptor on the surface of Kc cells. This 
observation proves that the secreted Bnl protein carrying wild type furin recognition 
sequences interacts only with surface of the cells expressing Btl receptor (Figure 26C–
C’’’). Therefore, the binding of wild type Bnl was considered to be specific. 
Interestingly, similar to the cleavable Bnl variant, the secreted EGFP-BnlMFS1-4-Myc 
protein was found co-localized with Btl-expressing cells. No interaction with cells that 
do not express the FLAG-tag could be observed (Figure 26D–D’’’) , indicating that 
despite the impaired furin cleavage sites, this Bnl variant still shows strong and 
specific binding to the receptor. The supernatants from mock-treated Kc cells were 
used as a control for the specificity of the anti-GFP antibody in this assay and showed 
no background staining (Figure 26E–E’’’). 
Taken together, the described ligand-receptor binding experiment argues 
strongly that the processing of the Bnl protein is not required for its specific 
interaction with Btl receptor in Drosophila cell culture. 
 
3.3.2 Bnl with impaired furin recognition sites shows dominant negative activity in 
Drosophila embryos 
 The described above experimental data showed that the unprocessed Bnl 
protein is still able to bind its receptor. However, this experiment does not 
demonstrate if the pre-mature growth factor can also cause FGFR activation and 
induce downstream signaling in vivo.  
Bnl has two central functions during Drosophila embryonic development: (i) it 
is required for the guidance of embryonic tracheal branches in order to create and 
shape an elaborated net of epithelial tubules, which will later supply oxygen to 
different tissues and organs of emerging larvae and (ii) Bnl regulates the final 
intracellular outgrowth of the terminal branches towards the target cells (Introduction 
1.2.3, 1.4.2; Samakovlis et al., 1996a; Uv et al., 2003). In the absence of functioning 
FGF signaling tracheal branches fail to migrate accordingly to the developmental 
pattern and do not form secondary and other lower range branches (Sutherland et al., 
1996). However, in case when Bnl protein is expressed ectopically in wild type 
background, tracheal branches change their usual direction of growth and start 
migrating towards the new growth factor source (Sutherland et al., 1996). 
Furthermore, upon overexpression, Bnl introduces the fate of terminal cells within the 
majority of tracheal cells resulting in the massive outgrowth of terminal branches. 
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Therefore, developing trachea of Drosophila embryo represents a perfect model 
system to study the biological function of Bnl protein variants both by loss-of-function 
experiments but also in gain-of-function experiments. Due to the highly dynamic Bnl 
protein expression during embryogenesis it was not possible to rescue the bnl loss-of-
function (LOF) tracheal phenotype using the GAL4/UAS system (Brand and Perrimon, 
1993). Therefore, an ectopic expression approach was employed in order to trace Bnl 
biological activity. 
The GAL4/ UAS expression system (Materials and methods 2.4.3; Brand and 
Perrimon, 1993) was utilized to provide tissue-specific ectopic expression of transgenic 
Bnl constructs. The 69BGal4 fly line was employed to induce UAS-controlled gene 
expression all over the embryonic ectoderm. Three different UAS fly lines were utilized 
in this experiment. The full length wild type bnl sequence (UAS-bnl) provides a 
positive control for the ectopic Bnl activity. Another transgenic line carries bnl ORF 
with impaired N-terminal furin cleavage sites (UAS-bnlMFS1,2), so N-terminal 
processing of this Bnl variant cannot occur. The third transgenic line enables the 
expression of the non-cleavable Bnl variant with all four furin consensus motives 
mutated (UAS-bnlMFS1-4). All constructs were generated without fusion tags to avoid 
phenotypes that might be caused by the tags. The three described Bnl transgenic fly 
lines were crossed with the ectodermal 69BGal4 driver line. F1 progeny embryos were 
harvested and chemically stained with 2A12 antibody in order to visualize lumen of the 
developing tracheal system. Further the immunostained embryos were subjected to 
the bright-field microscopy. 
As shown in Figure 27A, a wild type embryonic tracheal system represents a 
highly-ordered pattern of the tracheal branches. The ectopic expression of the wild 
type Bnl transgenic protein all over in the embryonic ectoderm almost completely 
destroys this pattern as a result of a mis-positioned FGF signaling. The abnormally 
thickened “chain-like” dorsal trunk and the appearance of multiple densely localized 
tracheoles are the characteristic features of the 69BGal4 induced tracheal misguidance 
phenotype, which is caused by the transformation of almost all tracheal cells into 
terminal unicellular branches (Figure 27B). However, when UAS-bnlMFS1,2 Bnl variant 
with two impaired amino-terminal cleavage sites was ectopically expressed in the 
same tissue, none of these changes was detected, the tracheal system pattern of 
these embryos looks as in wild type animals (Figure 27C). Similar to this, the 
misexpression of completely non-cleavable UAS-bnlMFS1-4 showed no tracheal 
misguidance phenotype. (Figure 27D). These results clearly indicate that Bnl 
processing is required to provide proper FGF signaling in gain-of-function experiments.  
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Figure 27: Bnl processing is required for its activity in Drosophila embryos. (A) Wild 
type tracheal system visualized with the 2A12 antibody (DT – dorsal trunk (primary branch); SB 
– secondary branches; TB – terminal branches (tracheoles). (B) Tracheal misguidance 
phenotype caused by ectopic expression of the wild type Bnl in the embryonic ectoderm. Ectopic 
ectodermal expression of the N-terminally uncleavable (UAS-bnlMFS1,2) (C) and the 
uncleavable Bnl variant (UAS-bnlMFS1-4) (D) introduces no tracheal misguidance phenotype. 
(E) Ectopic expression of UAS-bnl in the tracheal system also results in tracheal misrouting. 
Ectopic expression of UAS-bnlMFS1,2 (F) and UAS-bnlMFS1-4 (G) Bnl variants in the trachea 
cells does not introduce the misguidance, but instead causes the bnl loss-of-function phenotype 
(H). 
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The loss of activity of the two mutated Bnl variants can be explained by two 
mechanisms: first, the processing may be needed for the effective transport of the 
ligand. In the wild type situation the Bnl protein is secreted by epidermal cells and has 
to travel certain distance in the extracellular matrix in order to eventually interact with 
the Btl receptor of the tracheal tip cells (Sutherland et al., 1996; Imam et al., 1999). 
It is possible that in the represented experimental setup the mutated Bnl protein 
variants could not migrate to interact with Btl receptor. Another possible explanation 
of the ineffective signaling caused by non-cleaved Bnl variants could be that the too 
long and thus misfolded ligands are not able to provide receptor dimerization and thus 
trigger FGF signal transduction. 
In order to distinguish between the described models, the three Bnl constructs 
were ectopically expressed in the embryonic tracheal system cells using btlGal4 driver 
line, so that the Btl receptor and the Bnl protein variants are co-expressed within the 
same cell, excluding the necessity of ligand transportation. As shown in Figure 27E, 
embryos resulting from btlGal4 female flies crossed to male animals carrying the 
cleavable wild type Bnl variant, show severe tracheal misguidance phenotype, similar 
to that seen with 69BGal4 induced FGF expression. However, when either of the two 
mutated Bnl constructs was expressed in the trachea, no misrouting phenotype was 
detected (Figure 27F, G). 
This observation indicates that the uncleaved FGF ligands fail to induce Btl 
receptor activation. Moreover, in some of the embryos expressing the non-cleavable 
Bnl variant severe breaks in the dorsal tracheal trunk were revealed (Figure 27H). 
Such interruptions in the dorsal trunk are not the cause of gain-of-function 
experiments but they represent one of the characteristic traits of the bnl LOF 
phenotype (Sutherland et al., 1996). The appearance of this phenotype may indicate 
that the uncleaved Bnl protein is able to act as a dominant negative form of the 
ligand. It is secreted from the tracheal cells, readily binds to the Bnl receptor of the 
same cells and blocks it, thus preventing the receptor from interaction with 
endogenous Bnl ligands and thereby causing the observed bnl LOF phenotype. 
Taken together, the represented data strongly suggests, that proteolytic 
processing is required for the proper biological activity of Bnl in vivo. Moreover, 
though the uncleavable Bnl protein is able to bind the Btl receptor, the dominant 
negative effect observed in Drosophila embryos indicated that the Bnl precursor is 
unable to induce downstream signaling. 
  RESULTS 
_________________________________________________________________________ 
78 
 
3.3.3 Non-cleavable Bnl variants are expressed but not functional in Drosophila 
embryos 
 Since there was no apparent gain-of-function FGF activity detected in embryos 
expressing mutated Bnl variants, it is necessary to prove, that these transgenic 
proteins were expressed. Therefore, whole mount in situ RNA hybridization was 
performed to detect ectopically expressed mRNA encoding Bnl protein variants. As 
represented in Figure 28A, an ectopic expression of a control UAS-bnl transgene with 
btlGal4 driver can be revealed in the developing trachea with a bnl antisense RNA 
probe. Similar tracheal staining was detected when both UAS-bnlMFS1,2 and UAS-
bnlMFS1-4 mutated Bnl variants were expressed with the btlGal4 driver line (Figure 
28B and C). Moreover, anti-Bnl immunostaining was carried out in embryos expressing 
the non-cleavable Bnl construct to further prove the protein expression. The antiserum 
detecting the amino-terminal part of the Bnl protein was kindly provided by Mark 
Krasnow (Stanford, USA; Jarecki et al., 1999). The immunostainig clearly detects 
presence of the ectopically expressed mutated Bnl protein in tracheal cells (Figure 
28D). 
Thus, the results show that the non-cleavable Bnl variants are effectively 
expressed in the embryos as well as the wild type protein, suggesting that the 
mutations of the furin cleavage sites are responsible for the lack of Bnl biological 
activity. 
 
 
 
 
 
 
 
 
 
Figure 28: Mutated Bnl variants are expressed in Drosophila embryos. (A) In situ 
hybridization of wild type Bnl ectopically expressed in the trachea. (B) Ectopic expression of 
UAS-bnlMFS1,2 construct detected in the tracheal system. (C) Ectopic expression of the 
uncleavable Bnl variant (UAS-bnlMFS1-4) in the tracheal cells revealed by in situ hybridization. 
(D) Ectopic tracheal expression of UAS-bnlMFS1-4 detected with the anti-BnlN antibody. 
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3.3.4 N- and C-terminal parts of Bnl protein are not required for its in vivo activity  
 The experiments revealed that the uncleavable Bnl protein is not active, 
indicating the the proteolytic processing is indeed required for the activation of Bnl. If 
this is the case, the released central part of the protein with the conserved FGF 
domain should be biologically active. 
To explore this hypothesis, two additional transgenic lines were generated that 
allow the expression of a N-terminal shortened Bnl protein and a N- and C-terminal 
shortened protein that would represent the fully processed Bnl protein. The first fly 
line contains an untagged bnl sequence lacking the amino-terminal region up to the 
second cleavage site (FS2) starting exactly with the amino acids following the furin 
recognition motif (UAS-BnlSTV) (Figure 29A). The second line carries the fully 
truncated Bnl form with both the N- and the C-termini deleted (UAS-BnlSTV-GGK) 
(Figure 29B). The tissue-specific ectopic expression of truncated UAS Bnl constructs 
was induced using 69BGal4 and btlGal4 driver lines described in the section 3.3.2. 
Embryos resulting from this cross were harvested and stained using the 2A12 antibody 
to visualize the tracheal lumen. The immunostained embryos were screened for the 
tracheal misguidance phenotype using bright-field microscopy.  
 
 
 
 
 
 
 
 
 
 
Figure 29: Bnl truncated variants show FGF activity in Drosophila embryos. (A) 
Schematic representations of the N-terminally truncated (UAS-bnlSTV) and (B) both N- and C-
terminally truncated (UAS-bnlSTV-GGK) Bnl transgenic variants. Ectopic ectodermal expression 
of UAS-bnlSTV (C) and UAS-bnlSTV-GGK (D) causes misgudance of tracheal branches. Tracheal 
expression of UAS-bnlSTV (E) and UAS-bnlSTV-GGK (F) with btlGal4 also results in the tracheal 
misguidance phenotype. In C-F embryonic tracheal system is visualized with the 2A12 antibody. 
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As represented in Figure 29, the truncated Bnl variant mimicking the N-terminally 
processed protein shows a clear tracheal misguidance phenotype when ectopically 
expressed using both 69BGal4 (Figure 29C) and btlGal4 (Figure 29E) driver lines. 
Similar to this, the misexpression of the Bnl variant with N- and C-termini truncated 
causes the remarkable rerouting of the tracheal branches (Figure 29D and F). 
Brought together, the represented data strongly indicates that the amino- and 
carboxy-terminal Bnl protein parts, including furin recognition motives, are not 
required for the proper FGF signaling in vivo and the proteolytic processing serves to 
release the functional FGF domain. 
 
3.3.5 Bnl processing is required in the secreting tissue 
 The gain-of-function experiments clearly showed that the proteolytic processing 
is required to activate the Bnl protein and that only the central part including the FGF 
conserved domain is required for the activation of the Btl receptor. However, these 
experiments do not allow to conclude that also the endogenous Bnl protein has to be 
processed to become active. 
In order to investigate this issue, the processing of the endogenous Bnl protein 
was selectively blocked by the expression of α1-PDX protease inhibitor in different 
embryonic tissues. A tissue-specific expression of the inhibitor was achieved by 
employing the UAS/Gal4 inducible expression system (Brand and Perrimon, 1993). 
The cell culture results clearly proved that Bnl is processed during its synthesis within 
the secreting cells. Therefore, the processing should be specific to the epidermis that 
include the bnl-expressing cells but should not be required in the signal receiving cells 
of the tracheal system. Therefore, the specific furin inhibitor α1-PDX was first 
expressed within the tracheal cells using the btl-Gal4 driver line as a control. As 
expected, no tracheal system phenotype could be observed (Figure 30A and C). Flies 
carrying the bnlGal4 driver were utilized to provide an expression of the UAS-α1-PDX 
transgenic construct selectively in Bnl secreting ectodermal cells, although based on 
the highly dynamic expression changes and the time delay of expression using the 
Gal4/UAS system only weak effects could be expected. As shown in Figure 30D, 
embryos resulting from this cross have gaps in the main dorsal tracheal trunk that are 
characteristic of the bnl loss-of-function phenotype (Figure 30B). This phenotype 
becomes more apparent, when UAS-α1-PDX is expressed throughout the embryonic 
ectoderm under control of the 69BGal4 driver (Figure 30E).  
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Figure 30: Bnl processing is required in the secreting cells. Embryonic tracheal system is 
stained with the 2A12 antibody (A) Wild type tracheal system. (B) Strong bnl loss-of-function 
tracheal phenotype (dorsal tracheal trunk is not formed). (C) Tracheal expression of the α1-PDX 
inhibitor does not cause any tracheal phenotype. (D) A1-PDX expression in Bnl secreting cells 
introduces the weak bnl LOF phenotype. Expression of α1-PDX in the ectoderm (E) and 
ubiquitously in the embryo (F) results in the strong bnl LOF phenotype. 
 
Moreover, a strong and ubiquitous inhibition of Bnl cleavage with the tubGal4 driver 
resulted in a further increase of the phenotype. As shown in Figure 30F, the dorsal 
trunk failed to form in these animals, as it is observed in embryos with a strong bnl 
mutant alleles (Sutherland 1996). 
Thus, the experimental data supports the cell culture results proving also in 
vivo, that Bnl protein processing occurs only in the secreting tissue and is not required 
in the target tracheal cells. Furthermore, the represented experiment is in vivo 
evidence, that an impairment of Bnl processing by the inhibition of the furin protease 
activity has a negative impact on the embryonic tracheal development. This result 
therefore, strongly indicates that the proteolytic processing is also required for the 
activation of the endogenous Bnl protein. 
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3.3.6 Drosophila Furin1 expression overlaps with that of Bnl 
 As was shown in section 3.2.5, Drosophila Furin1 proprotein convertase was 
identified as a protease required for Bnl processing in cell culture. Therefore, it is 
interesting to investigate, whether dfur1 and bnl genes would demonstrate a 
temporally and spatially overlapping expression pattern in Drosophila embryo. bnl 
gene expression becomes detectable in the ectoderm in multiple spots surrounding the 
arising tracheal pits at stage 11 of embryogenesis (Sutherland et al., 1996). During 
stages 12 and 13 bnl expression dynamically changes, corresponding to formation and 
growth of primary tracheal branches (Figure 31A). At stage 14 the ectodermal bnl 
expression is diminished and eventually cut off. In order to correlate the dfur1 
expression pattern with that of bnl, whole mount RNA in situ hybridization with a dfur1 
antisense probe was performed using w1118 Drosophila embryos of different stages to 
trace the localization of dfur1 mRNA. Stained embryos were mounted on slides and 
dfur1 expression was visualized using bright-field microscopy. According to the 
previous observation, embryos of early stages show ubiquitous dfur1 mRNA 
localization, so that it is not possible to distinguish any specific expression pattern 
(Roebroek et al., 1993). However, at stage 13 dfur1 expression accumulates laterally 
in epidermal spots, in the area where bnl is expressed at the same time point (Figure 
31A and B; Roebroek et al., 1993; Sutherland et al., 1996). 
Thus, the observed overlapping expression pattern of bnl and dfur1 strongly 
indicates, that Dfur1 proprotein convertase could be the protease required for the Bnl 
processing in Drosophila embryos as well as in cell culture. 
 
 
 
 
 
 
 
Figure 31: dfur1 and bnl RNA in situ hybridization. (A) Whole mount in situ hybridization 
with the bnl antisense RNA probe carried out in w- embryos. (B) dfur1 gene expression 
detected in stage 13 embryos. Both genes are dynamically expressed in the lateral epidermis of 
late embryo. 
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3.3.7 Embryos lacking Dfur1 demonstrate impaired tracheal development  
In order to further investigate relevance of Dfur1 protease for Bnl signaling in 
vivo, Drosophila embryos lacking a functional dfur1 gene were screened for the bnl 
tracheal phenotype. Since no strong alleles of dfur1 gene are available, embryos of a 
cross of a dfur1 gene deficiency in trans with a P-element insertion in the 5’-UTR of 
the dfur1 gene were analyzed. The mutant embryos were identified using β-
galactosidase marked balancer chromosomes of the two parental strains. The embryos 
were harvested and stained with the 2A12 antibody to visualize the developing 
tracheal system. In addition, anti-β-Galactosidase staining was performed to identify 
mutant embryos. The immunostained embryos showing no β-Galactosidase staining 
were subjected to the bright field microscopy. About 15% of the explored embryos 
showed defects in tracheal system development. As represented in Figure 32, 
numerous breaks in the main trunk were detected in these animals. Moreover, some 
of the dorsal tracheal branches were missing as a result of impaired Dfur1 activity. 
The observed phenotypes resemble the weak bnl loss-of-function phenotype. 
However, it was previously shown, that Drosophila furins participate in the processing 
of Decapentaplegic (Dpp) proprotein, another signaling molecule required for 
embryonic tracheal system formation (Myat et al., 2005; Künnapuu et al., 2009). 
Therefore, it is not yet clear if the observed phenotype represents the result of 
a reduced bnl activity or, alternatively, both Bnl and Dpp signaling pathways are 
impaired. Further in vivo experiments are required to explore this issue. 
 
 
 
 
 
 
Figure 32: dfur1 mutant embryos show the impaired tracheal development. Drosophila 
embryo lacking functional Dfur1 protein demonstrates numerous breaks in dosal trunk (arrows) 
and missing dorsal brunches (arrowheads). Embryonic tracheal system is stained with the 2A12 
antibody. 
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3.3.8 Dfur1 activity is required for Bnl signaling during embryonic tracheal system 
development 
One of the commonly utilized approaches to connect the activities of two gene 
activities to the same signaling pathway in vivo is the genetic interaction assay. For 
this purpose, the dosage of the corresponding genes is decreased by 50% in the 
organism. Such a reduction of the gene dosage by itself has normally no effect. 
However, if the two proteins functionally belong to the same biological process, 
simultaneous reduction of their gene dosage will result in a phenotype that resembles 
a homozygous loss-of-function phenotype of each of these genes, despite that both of 
them are in fact in the heterozygous state. 
In order to check whether Dfur1 proprotein convertase indeed participates in 
the Bnl signal-transduction pathway, a dfur1 deficiency heterozygous fly line was 
crossed with flies carrying the bnlP1 loss-of-function mutation. As was earlier 
described by Sutherland et al., 1996, in homozygous state this mutation causes a 
complete failure of the tracheal branching and dorsal trunk formation (Figure 30A), 
whereas heterozygous mutants do not show a tracheal phenotype (Sutherland et al., 
1996). F1 embryos resulting from the genetic interaction cross were harvested and 
stained with the 2A12 antibody for tracheal lumen detection and with the anti-β 
galactosidase antibody to visualize the wild type balancer chromosome. Embryos 
lacking one copy of each gene were screened for the tracheal system phenotype. 25% 
of the observed trans-heterozygous embryos showed impaired tracheal development. 
In particular, in some animals the anterior and posterior dorsal trunk branches failed 
to fuse together (Figure 33A), additionally, in other cases dorsal or ganglionic tracheal 
branches were missing (Figure 33B). This result strongly indicates that Dfur1 protease 
activity is required for the function of the Bnl signaling pathway in the tracheal 
system. 
 
 
 
 
 
Figure 33: Genetic interaction of dfur1 and bnl in developing tracheal system. Embryos 
double trans-heterozygous for dfur1 and bnl mutant alleles show severe bnl LOF phenotype.  
Embryonic tracheal system is visualized with the 2A12 antibody. (A) In this embryo fusion of 
the anterior and posterior branches of the dorsal trunk did not occur. (B) The embryo has 
impaired dorsal trunk fusion and missing dorsal (arrowheads) and ganglionic (arrow) branches. 
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3.4 Proteolytic processing of vertebrate homologues of Bnl 
Drosophila Bnl represents the functional homolog of vertebrate FGF10 that 
is involved in branching morphogenesis of the lung (Min et al., 1998; Introduction 
1.2.3). Based on the current results, it is possible that proteolytic processing also 
contributes to the modulation of FGF10 signaling in vertebrates. In silico protein 
alignment of Bnl and FGF10 homologues from Xenopus laevis, Gallus gallus, 
mouse and human was performed to investigate this hypothesis (Materials and 
methods 2.5.2). This approach revealed a potential furin recognition motif (–R–
H–V–R–) located five amino acids upstream of the FGF homology domain in all 
these proteins (Figure 34A). 
In order to assess, whether the identified furin recognition motives are utilized 
for vertebrate FGF10 processing, a human FGF10 carrying C-terminal 10xMyc-tag was 
expressed in Drosophila Kc cells (Figure 34B) and cell supernatant was subjected to 
Western blot analysis with the anti-Myc antibody. As shown in Figure 34C, the 
secreted hFGF10 migrates as two Myc-positive bands of 38 and 34 kDa. However, 
when co-expressed with the α1-PDX construct, the lower band vanishes from the blot.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 34: Proteolytic processing of vertebrate FGF10 homologues. (A) Sequence 
alignment of Bnl and FGF10 homologues from different vertebrate species. Conserved 
minimal furin recognition motif identified upstream of the FGF domain is shown inside the 
black frame. Bnl cleavage site FS2 is underlined. Beginning of the FGF domain is shown 
with an arrow. (B) A schematic drawing of the tagged hFGF10 protein. Location of furin 
recognition motif is indicated with a red arrow. (C) Western blot analysis of the FGF10 
construct in the presence of α1-PDX inhibitor secreted from Drosophila cells. Tagged 
hFGF10 is detected with the anti-Myc antibody. N-terminally cleaved protein is marked 
with an arrow. A schematic drawing of the revealed hFGF10 forms are shown on the right. 
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This result suggests that similar to Bnl, hFGF10 undergoes proteolytic cleavage in its 
N-terminal region. Moreover, according to the obtained data, this processing relies on 
the activity of a protease of SPC family, since the addition of the specific inhibitor 
prevented the cleavage. 
 Taken together, the experimental data of the present study shows that 
Drosophila FGF homologue Bnl that is required for development of embryonic tracheal 
system undergoes proteolytic processing in secreting cells. The maturation process 
includes cleavage of the Bnl proprotein in its N- and C-termini and is carried out by 
the specific Drosophila Furin1 proprotein convertase. It was shown, that the non-
cleaved Bnl is readily secreted from the expressing cells and, moreover, is able to 
specifically interact with the Btl receptor on the cellular surface. However, the 
unprocessed Bnl forms are unable to induce downstream FGF signaling in vivo. 
Analysis of dfur1 and bnl mutant embryos indicates that Bnl maturation is necessary 
for the correct formation of the embryonic tracheal system and Dfur1 plays an 
important role in this process, indicating that the characterized proteolytic processing 
of Bnl is essential for its biological activation in vivo. Moreover, the vertebrate 
homologue of Bnl, hFGF10, was shown to be proteolytically cleaved by a protease of 
the SPC family in Drosophila cells, suggesting that the proteolytic processing of Bnl 
homologues is evolutionary conserved. 
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4 DISCUSSION 
The phenomenon of post-translational proteolytic processing of growth 
factors and other signaling peptides is widespread in eukaryotes. Proteolytic 
cleavage is known to be a part of maturation process of the β-nerve growth factor 
(βNGF), members of the transforming growth factor-β (TGF- β) superfamily, 
platelet derived growth factor (PDGF), vascular endothelial growth factor (VEGF) 
and others (Bresnahan et al., 1990; Dubois et al., 1995; Siegfried et al., 2003; 
Stacker et al., 1999). Precursor protein processing usually occurs at dibasic 
amino acid residues and members of the subtilisin-like proprotein convertase 
(SPC) family of enzymes were shown to be responsible for this process (Steiner, 
1998). For most growth factors and neuropeptides endoproteolytic cleavage 
represents an activation step and therefore is essential for their biological 
activity. 
This work represents the first report about post-translational processing of 
Drosophila fibroblast growth factor Branchless (Bnl). This protein is involved in 
development of embryonic and larval tracheal system and represents the 
functional homologue of human FGF10 (Min et al., 1998). The experiments 
performed in this study show that Bnl is initially synthesized as a larger precursor 
protein, which undergoes proteolytic activation in secretory cells. Cleavage 
removes the extended N- and C-terminal parts of the protein and releases the 
functional FGF homology domain. In this study, Drosophila Furin1 (Dfur1) was 
identified as a protease required for Bnl processing. In vivo analysis indicated 
that proteolytic cleavage by Dfur1 is required for Bnl protein activation and is 
essential for its proper function during morphogenesis of embryonic tracheal 
system. Moreover, analysis of vertebrate homologues of Bnl suggests the 
conservation of the observed furin-mediated regulation of FGF function in course 
of evolution. 
 
4.1 Proteolytical processing of Drosophila Bnl protein 
 Drosophila FGF homologue Bnl was discovered almost 15 years ago 
(Sutherland et al., 1996). Despite the huge evolutional distance between 
vertebrates and invertebrates, the FGF domain of Bnl demonstrates high 
homology with human and other vertebrate FGFs (Sutherland et al., 1996). From 
a functional point of view, Bnl is able to induce cell migration and differentiation 
via specific interaction with its receptor Btl and is known to function as a 
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chemoattractant for the cells of Drosophila tracheal system (Sutherland et al., 
1996; Ribeiro et al., 2002). However, in contrast to all known vertebrate FGFs, 
which are relatively small in size, the Bnl protein is unusually large (Sutherland et 
al., 1996; Ornitz and Itoh, 2001). It contains extended N- and C-terminal regions 
flanking the conserved FGF domain, making the Bnl protein about three times 
longer than any of the vertebrate FGFs (Sutherland et al., 1996).  
Current study provides information about post-translational regulation of 
the Bnl protein length and biological activity. The performed experiments clearly 
indicate that Bnl is proteolytically cleaved in its N- and C-termini in cell culture as 
well as in Drosophila embryos. This cleavage occurs intracellularly and all forms 
of the protein can be secreted from the cells and subsequently detected in 
conditioned medium. The experiments showed that Bnl processing results in 
release of the central part of the protein that contains the conserved FGF domain. 
Since there is no reliable antibody that is able to specifically bind the Bnl FGF 
domain, detection of the cleaved protein was carried out using N- and C-
terminally tagged versions of Bnl. This approach reveals the N- and C-terminal 
parts of the cleaved growth factor. However, the central domain could only be 
visualized indirectly with the antibody detecting Bnl fusion tags due to incomplete 
cleavage of the proprotein (see Figures 13, 15 and 17). Subsequent analysis of 
Drosophila embryo extracts has demonstrated that Bnl cleavage also takes place 
in vivo (Figure 15). Furthermore, the calculated molecular mass of the released 
central FGF domain of Bnl is about 34-37 kDa, which corresponds to the reported 
size of vertebrate FGFs. 
There are only few reports about post-translational proteolytic processing 
of FGFs available. It was previously shown that Xenopus laevis FGF3 is 
proteolytically modified by an unknown protease presumably of the proprotein 
convertase family (Kiefer et al., 1993; Antoine et al., 2000). Similar to Bnl, this 
protein is processed in its N- and C-termini. Other evidence that the FGFs can be 
proteolytically processed comes from a study on mouse FGF4 (also known as 
kFGF) that is processed in its N-terminal region (Kosaka et al., 2009). A single 
known human FGF, which was shown to undergo proteolytic cleavage, is FGF23 
(Fukumoto, 2008). It was recently reported that FGF23 is cleaved in its C-
terminal region by a yet unidentified protease of SPC family (Benet-Pages et al., 
2004). As described in White et al., 2001, cleavage of FGF23 occurs 
intracellularly or during its secretion. Thus, according to the available data, 
proteolytic processing is not common for members of the vertebrate FGF family. 
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However, the experimental evidence from this study indicates that 
Drosophila FGF Bnl is produced as a precursor that undergoes proteolytic 
maturation in secreting cells. Moreover, it was described recently that two other 
Drosophila FGFs, Pyr and Ths, which have comparable to Bnl length, undergo 
intracellular cleavage in Drosophila releasing their N-terminal parts containing the 
FGF domain to extracellular space (Tulin and Stathopoulos, 2010). Altogether,  
these data suggests that the proteolytic cleavage of large precursors is a common 
mechanism of FGF modification in Drosophila. 
 
4.2 Relevance of anterograde trafficking for Bnl processing and secretion 
Vertebrate FGFs differ in their subcellular localization and secretory 
behavior. Most of them are secreted from producing cells using a hydrophobic 
signal peptide that serves to target the protein to the classical secretory pathway 
of the cell. Such proteins are directly synthesized into the ER lumen and further 
transported to the Golgi apparatus by a anterograde trafficking mechanism. This 
mechanism includes formation of the coated protein II (COPII) vesicles (reviewed 
in Fromme et al., 2008). In the Golgi complex the proteins are sorted according 
to their final destination and purpose and undergo different types of post-
translational modification including glycosylation and proteolytic cleavage. 
Proteins that are assigned for secretion leave the late Golgi compartment as part 
of secretory vesicles. These vesicles are further transported to the cellular 
periphery and fuse with the plasma membrane releasing their content to the 
extracellular space (Reynaud and Simpson, 2002). However, some members of 
the vertebrate FGF family including FGF1, FGF2, FGF9, FGF16 and FGF20 do not 
have a classical signal sequence, but are nevertheless secreted from producing 
cells (Miyake et al., 1998; Ochmachi et al., 2000; Miyakawa et al., 1999; Revest 
et al., 2000), indicating that these FGFs utilize an alternative secretory pathway 
independent from the ER and Golgi complex. 
As previously described, the Bnl protein carries a predicted 24 amino acid 
signal sequence in its N-terminus (Sutherland et al., 1996). By inhibiting the 
formation of COPII vesicles within Drosophila Kc cells, it was possible to 
investigate whether the conventional secretory pathway is employed for Bnl 
export and effective processing. As represented in Results 3.1.4, the inhibition of 
cellular anterograde trafficking almost completely abolishes Bnl processing and 
secretion (Figure 17). This result indicates that Bnl is secreted using the classical 
secretory rout and thus relates it with conventionally secreted members of FGF 
family. These data also suggests, that Bnl has to be transported to the Golgi 
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apparatus to be cleaved. This hypothesis is further confirmed by the subsequent 
results, showing that Bnl is processed by a furin protease, which preferentially 
localizes in the Golgi complex (Results 3.2.5, 3.3.7, 3.3.8). 
 
4.3 N-linked glycosylation of the Bnl protein 
 Western blot analysis showed that the Drosophila Bnl protein has 
dramatically higher molecular weight than was expected from its amino acid 
sequence. Subsequent experiments indicated that Bnl, similar to the members of 
vertebrate FGF family, carries N-linked glycosylation (see Introduction 1.2.1, 
Results 3.1.3).  
 Sugar modifications fulfill diverse biological functions within the cell. They 
serve as recognition markers, regulate the turnover of proteins and may 
contribute to the glycoprotein activity (Helenius and Aebi, 2004; Lederkremer, 
2009). Furthermore, they are implicated in correct protein folding and are known 
to contribute to protein stability (Bellosta et al., 1993; Hanson et al., 2009). 
Glycosylation is an enzymatic process and was shown to occur in different cellular 
compartments, including the ER and the Golgi complex (reviewed in Hardingham 
and Fosang, 1992). There are several known types of protein glycosylation (N- 
and O-linked glycosylation, phospho-glycosylation and others), but N- and O-
linked sugar modifications are the most widespread ones. 
Treatment of Bnl with N-glycosidase reduces the apparent molecular 
weight of the cleaved N-terminal part of the protein, indicating that Bnl is 
modified at its N-terminal region that is proteolytically removed. Therefore, this 
modification cannot have a function in the activity of the secreted mature ligand. 
Based on Western blot analysis of full length Bnl, the glycosylation masks the GFP 
antibody epitope at the N-terminus of the protein (see Results 3.1.1 and 3.1.3). 
The high molecular weight products of partial Bnl cleavage could be detected with 
the anti-GFP antibody only after the treatment with N-deglycosydase (Figure 16). 
However, this approach could only partially improve N-terminus detection and the 
secreted full length protein was still invisible with the anti-GFP antibody. This 
indicates that along with the N-linked glycosylation Bnl carries other types of 
post-translational modification. Based on in silico prediction (Materials and 
methods 2.5.4), the Bnl protein carries 5 potential N-linked and two O-linked 
glycosylation sites (Figure 35). The two N- and one O-glycosylation targets are 
located in the Bnl N-terminal region close to the GFP fusion tag. Therefore, these 
modifications are likely to be responsible for the impaired binding of the antibody. 
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Figure 35: In silico predicted sites of Bnl N- and O-linked glycosylation. Schematic 
representation of the tagged Bnl protein with marked predicted glycosylation sites. N-
linked glycosylation is shown with red vertical lines; O-glycosylation is marked with green 
vertical lines. 
 
Furthermore, the unglycosylated (and therefore detectable with the anti-
GFP antibody) full length Bnl could only be revealed within the cells and not in 
conditioned medium (Figure 13). This suggests that Bnl modification may protect 
the protein from proteolytic processing. A similar effect was demonstrated for the 
mouse FGF4 (Bellosta et al., 1993). This protein is usually secreted from 
expressing cells as a N-teminally glycosylated peptide. However, in the absence 
of glycosylation it appears instable and undergoes proteolytic processing in its N-
terminal region (Bellosta et al., 1993). Hence, the unidentified glycosylation 
masking the GFP antibody epitope of Bnl may serve as a negative regulator of its 
proteolytic cleavage within the cell. 
Moreover, based on the dramatic effect of N-linked glycosylation on Bnl 
molecular weight, it would be interesting to investigate if the observed 
modification has an impact on its intracellular sorting, secretion, extracellular 
stability or biological function. The reported glycosylation could be required for 
the correct transport of the Bnl protein from the ER to the Golgi complex. 
Additionally, the described N-glycosylation may serve as a recognition marker for 
the subsequent proteolysis. In order to test all these hypotheses, the modified 
amino acids need to be subjected to mutational analysis.  
 
4.4 Characterization of Bnl cleavage sites 
 Identification of Bnl cleavage sites (see Results 3.2.1–3.2.4 & 3.2.7) 
showed that Bnl is cleaved in Drosophila by a furin proprotein convertase. 
According to available data, these proteases preferentially localize in the trans-
Golgi network (Molloy et al., 1994). Moreover, these enzymes are implicated in 
the majority of proteolytical processing at basic amino acid residues in the 
eukaryotic secretory pathway (Thomas, 2002). 
One of the Bnl N-terminal furin cleavage sites was identified six amino 
acids upstream of the conserved FGF domain, suggesting that the cleavage does 
not cause Bnl inactivation but rather represents the mechanism of growth factor 
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maturation (Results 3.2.3). The identified motif represents a minimal recognition 
sequence cleaved by a furin proprotein convertase. Subsequent in silico analysis 
revealed the presence of other three potential furin cleavage sites in the Bnl 
protein: one more site was found in the N-terminus and two in the C-terminus, 
surrounding the central FGF homology domain (Figure 23). Furin cleavage sites 
designated with numbers 2 and 3 (FS2 and FS3) are located proximally to the 
FGF domain and represent minimal furin recognition sequences. The other two 
furin consensus motives FS1 and FS4 are located distally and contain duplicated 
minimal sequences (Results 3.2.6). 
In order to estimate the relevance of each furin cleavage site for Bnl 
processing, the recognition motives were sequentially mutated using the site-
directed mutagenesis approach (see Results 3.2.7). This experiment revealed that 
FS1 and FS2 N-terminal furin motives can be utilized independently from each 
other for Bnl cleavage, since only the mutagenesis of both sites prevented the N-
terminal Bnl processing (Figure 24B). In contrast, site-directed mutagenesis of 
the C-terminal furin motives revealed that the mutation of FS4 alone was able to 
completely protect the Bnl C-terminus from proteolysis, indicating that FS3 motif 
is not utilized for the growth factor processing in Kc cells or – less likely – FS3 is 
only used after the cleavage at the FS4 (Figure 24C).  
As an alternative approach, the relevance of the identified cleavage sites 
for Bnl processing were analyzed on the basis of their evolutional conservation. 
The results of protein alignment described in the section 3.2.6, indicated that the 
four furin recognition sites identified in the Bnl protein are conserved in FGF 
homologues of other Drosophila species (Table 1). The alignment revealed a 
perfect sequence match for the FS1, FS2 and FS4 cleavage motives in all 
Drosophila Bnl homologues. However, the FS3 cleavage site showed a reduced 
sequence homology in the amino acids irrelevant for the cleavage and the site 
was not preserved in Drosophila mojavensis. This remarkably high degree of 
sequence identity of the three out of four cleavage sites suggests that the 
processing of Drosophila FGF homologues is essential for Drosophilidae 
development.  
The combined results of the mutagenesis and the conservation analysis 
strongly indicate that Bnl is processed by a furin protease that cleaves the protein 
at positions FS1, FS2 and FS4. The relevance of the FS3 for the proteolytic 
procession of Bnl remains unclear, since the performed experiment cannot rule 
out if this motif is used for the Bnl cleavage in vivo. Alternatively, the FS4 
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cleavage might be a prerequisite for the effective processing at the FS3. Further 
experiments are required to settle these issues. 
 
4.5 Drosophila Furin1 is responsible for Bnl cleavage 
Three proprotein convertases (Furin1 (Dfur1), Furin2 (Dfur2) and 
Amontillado (Amon)) were identified in Drosophila (Roebroek et al., 1991; 
Roebroek et al., 1995; Siekhaus and Fuller, 1999). Dfur1 and Dfur2 demonstrate 
high homology to the human furin protease and were recently shown to be 
implicated in proteolytical processing of Drosophila TGFβ homologue 
Decapentaplegic (Dpp). Moreover, the two furins have differential impact on Dpp 
processing and are involved in modulation of different aspects of its activity 
(Künnapuu et al., 2009). According to the sequence similarity, Drosophila Amon 
is related to the human prohormone convertase-2 (PC2). This protease was 
shown to have slightly different substrate specificity than furin and is involved in 
neuropeptide processing in vertebrates. Amon was shown to be enriched in the 
embryonic nervous system and was reported to regulate larval hatching behavior 
(Siekhaus and Fuller, 1999). However, Amon was not detected in the lateral 
embryonic ectoderm where Bnl is expressed during embryogenesis (Siekhaus and 
Fuller, 1999). Moreover, Amon was not found in Drosophila Kc cells where Bnl 
cleavage occurs. Thus, it seems to be unlikely, that this protease would 
contribute to the Bnl processing. 
The cell culture based experiments with RNAi-mediated silencing of the 
expression of either or both Drosophila furin (dfur) genes indicated, that only 
Dfur1 proprotein convertase is involved in the Bnl precursor cleavage (Results 
3.2.5; Figure 22). This result indicates that the cleavage of Bnl is regulated 
differently to the described process of Dpp cleavage that requires proteolytic 
activities of both Drosophila furins (Künnapuu et al., 2009). However, it is 
consistent with the previous study of dfur1 expression in Drosophila embryos 
(Roebroek et al., 1993) and with present results, showing that dfur1 transcript is 
expressed in lateral embryonic ectoderm, close to Bnl secreting cells at the stage 
13 of embryogenesis (Sutherland et al., 1996; Results 3.3.6). Thus, according to 
the experimental evidence and the available data, Bnl is proteolytically processed 
by Dfur1 proprotein convertase and both proteins overlap in their expression 
during late stages of Drosophila embryogenesis. 
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Human furin is known to catalyze the processing of various signaling 
proproteins in trans-Golgi network (TGN) (Thomas, 2002), therefore, it is likely 
that Bnl cleavage also occurs in this compartment. The co-secretion of all Bnl 
cleavage products to the supernatant may happen due to non-covalent 
attachment of the cleaved off domains to the central portion of the Bnl protein, as 
it known for mammalian Notch receptor (Kidd and Lieber, 2002). Alternatively, 
the processed N- and C-terminal parts may be individually secreted. Although 
these domains demonstrate no sequence similarity with known proteins 
(Sutherland et al., 1996), the performed experiments could not exclude that they 
carry individual biological functions not connected with the FGF signaling in 
Drosophila.  
Furthermore, similar to the human furin, Dfur1 also demonstrates dynamic 
subcellular localization and can be detected in the Golgi as well as on the cellular 
surface (De Bie et al., 1995). This raises the possibility that the Bnl protein may 
be cleaved inside the secretory granules. This would explain the appearance of 
the full length Bnl protein and both cleaved N- and C-terminal domains in 
conditioned medium (Figure 13). 
Taken together, the described experiments strongly indicate that Bnl 
undergoes proteolytic processing in the late secretory pathway by Dfur1 
protease. Further experiments are required to precisely identify the subcellular 
position of Bnl cleavage and the way of secretion of the cleavage products. 
 
4.6 In vivo relevance of Bnl protein processing: a gain-of-function study 
In order to investigate whether the proteolytic cleavage affects Bnl 
biological function, several cell culture and in vivo experiments were performed. 
The receptor-ligand binding assay described in section 3.3.1 showed that the 
non-cleavable Bnl precursor is efficiently secreted from the cells and is able to 
specifically interact with the cell surface receptor Btl (Figure 26). This indicates 
that the extended N- and C-terminal domains of the Bnl precursor do not prevent 
the formation of a receptor-ligand complex. However, it cannot be excluded that 
the kinetics and strength of this interaction would differ from that of the 
processed Bnl protein. 
Bnl is known to function as a chemoattractant for the embryonic trachea 
and is able to provide the directional growth of developing tracheal branches 
(Sutherland et al., 1996; Wolf and Shuh, 2000; Kadam et al., 2009). Therefore, 
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Bnl activity can be estimated in vivo by misguidance of tracheal branches in 
response to ectopically expressed Bnl. The results shown in section 3.3.2 indicate 
that Bnl protein variants, in which the N-terminal or all four furin cleavage sites 
were mutated, failed to guide growing tracheal branches when expressed in the 
ectoderm. In contrast, expression of the cleavable Bnl protein at the same 
location induced the misrouting of the embryonic tracheal branches (Figure 27E). 
This experiment shows that the proper Bnl processing is critical for its biological 
activity. However, since Bnl has to travel several cell diameters to reach Btl 
receptor expressed in the tracheal cells, it is not clear from this experimental 
design, if cleavage affects the motility of Bnl or it influences its activity as a 
ligand. 
The fact that the N-terminally non-cleavable Bnl variant demonstrates lack 
of biological activity similar to the completely uncleavable Bnl precursor could be 
explained in two ways. First, the C-terminal cleavage might be less important for 
the Bnl activation compared to the N-terminal processing. This hypothesis is 
consistent with the earlier observation that Bnl C-terminal cleavage in cell culture 
is generally less efficient than its N-terminal processing. Second, the N-terminal 
cleavage event may play a permissive role for the subsequent C-terminal 
processing of Bnl protein in vivo. Further experiments are needed to investigate 
these possibilities. 
To directly analyze the ability of the non-cleavable Bnl to activate the 
receptor, it was directly co-expressed with Btl within the tracheal cells. In this 
experimental approach, the uncleavable Bnl precursor was observed to induce a 
dominant negative (DN) effect and introduced a phenotype similar to the bnl loss-
of-function (LOF) phenotype (Sutherland et al., 1996; Results 3.3.2, Figure 27H). 
Thus, although the uncleavable Bnl is able to bind the Btl receptor, it cannot 
induce the receptor activation and provide downstream FGF signaling. Also, the 
uncleavable precursor occupies the receptor thereby blocking the binding of the 
endogenous active Bnl ligands and results in a DN effect. The described DN 
property of the uncleavable Bnl ligand is very similar to that reported for a 
platelet derived growth factor A (PDGF-A). Its non-cleavable form ARKA86 was 
shown to be effectively secreted from the cells and has been shown to have a 
dominant negative effect with respect to tumor induction in vivo (Siegfried et al., 
2003). Moreover, the fact that the ectodermal expression of the uncleavable Bnl 
variant does not induce the DN phenotype (Figure 27D) indirectly indicates that 
the N- and C-terminal domains impede the extracellular transport of the Bnl 
ligand. However, further experimental work is required to confirm this 
hypothesis. 
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Furthermore, the ectopic expression experiment using the cleaved central 
domain alone (Results 3.3.4) revealed that the released Bnl FGF domain is 
secreted, can move towards tracheal cells and activate the Btl receptor resulting 
in ectopic tracheal guidance (see Figure 29). This experiment shows that the FGF 
central domain is the only biologically active part of Bnl. 
There are only very few reports about proteolytic regulation of fibroblast 
growth factor activity. It was shown previously, that the processed FGF3 from 
Xenopus laevis demonstrates several folds higher affinity towards its receptor 
isoforms FGFR2 (IIIb) and FGFR2 (IIIc) compared to its precursor (Kiefer et al., 
1993; Antoine et al., 2000). Furthermore, cleavage products of mouse FGF4 
demonstrate 5 times higher affinity towards heparin than the precursor protein. 
(Bellosta et al., 1993). In contrast, proteolytic cleavage of human FGF23 was 
recently described to contribute to protein inactivation (Shimada et al., 2001). 
These observations indicate that proteolytic regulation is not conventional for the 
members of the FGF family and may cause activation as well as inactivation of 
the FGF ligands. 
Similar to the proteolytically activated vertebrate FGF3 and FGF4, Bnl 
proteolytic processing induces the release of the functional FGF domain and 
therefore provides Bnl with the ability to induce receptor activation. The results 
obtained in this work are in accordance with a model that Bnl cleavage is neither 
required for its secretion from the cells nor for its binding to the receptor. 
However, Bnl processing is essential for the induction of its ability to activate the 
Btl receptor in tracheal cells. The extended N- and C-terminal regions of the Bnl 
proprotein may cause spatial disturbances that hinder receptor dimerization and 
thereby prevent downstream signaling cascade. Moreover, since the truncated Bnl 
FGF domain is fully active, the cleaved N- and C-terminal regions are not required 
for the Bnl ligand function. 
 
4.7 In vivo relevance of Bnl protein processing: a loss-of-function study 
Since the promotor region of the Bnl protein is not yet characterized, it is 
impossible to test if the truncated central FGF domain alone would be sufficient to 
rescue the mutant bnl phenotype and if the uncleavable variant would be 
inactive. To circumvent this technical problem the cleavage of the endogenous 
Bnl was inhibited by the tissue-specific expression of the subtilisin-like proprotein 
convertase (SPC) inhibitor α1-PDX (Benjannet et al., 1997). Interference with the 
endogenous furin activity in the ectodermal cells that express Bnl results in bnl 
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loss-of-function (LOF) phenotype (Results 3.3.5, Figure 30). Furthermore, the 
expression of the furin inhibitor in the tracheal cells, where the endogenous Bnl 
protein is not expressed, had no effect (Figure 30C), showing that the Bnl 
precursor is cleaved only in the secreting cells. These results further confirm the 
relevance of Bnl processing for its in vivo function. 
Nevertheless, it is necessary to take into consideration that the utilized 
furin inhibitor is active against a broad spectrum of subtilisin-like proteases. 
Moreover, Drosophila Dpp was shown to participate in tracheal morphogenesis 
and it also requires proteolytic activation by furins (Steneberg et al., 1999; Myat 
et al., 2005; Künnapuu et al., 2009). Therefore, it is necessary to prove that the 
observed bnl phenotype is only induced by loss of specific Bnl processing by furin. 
As already discussed, Dfur1 protease is responsible for Bnl proteolytic processing 
(Results 3.2.5 and Discussion 4.5). Therefore it was investigated, if dfur1 activity 
is required for proper tracheal development. According to the experiment 
described in section 3.3.7, embryos lacking dfur1 expression show a phenotype 
similar to bnl LOF phenotype (Figure 32). Thus, both the inhibition of furin 
function in general using the α1-PDX inhibitor and the specific reduction of dfur1 
activity results in the same phenotype. Moreover, the genetic interaction 
experiment described in section 3.3.8 showed that concurrent 50% reduction of 
bnl and dfur1 gene dose results in a clear bnl loss-of-function phenotype (Figure 
33). These data suggest that the in vivo activities of bnl and dfur1 genes 
functionally belong to the same regulation circuit and that the observed tracheal 
system phenotype in dfur1 mutants is caused by the inhibition of Bnl proteolytic 
processing. 
Taken together, the combined cell culture and in vivo results show that the 
Bnl protein is proteolytically processed by Dfur1 protease in the secretory 
pathway of producing cells and that this cleavage is essential for the ligand 
activation. Moreover, only the released central FGF domain of Bnl is able to 
activate the Btl receptor in vivo, which is a prerequisite for the correct 
development of Drosophila tracheal system. 
 
4.8 Relevance of Bnl processing for vertebrate study 
The in silico analysis of Bnl homologues from several vertebrate species 
including human FGF10 revealed the conserved furin recognition site in the N-
terminal region of these growth factors (Figure 34A). Subsequent experiments 
have confirmed that the identified consensus motif of hFGF10 is cleaved in 
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Drosophila cell culture by a protease of the SPC family of proteolytic enzymes 
(Results 3.4, Figure 34C). FGF10 is known to function during development of 
vertebrate lung and, similar to Bnl, provides directional cues for migration of 
respiratory epithelium. Further experimental work is needed to precisely identify 
the protease responsible for the FGF10 cleavage and assess whether the 
observed proteolytic processing occurs in mammalian cells as well. It is also to be 
explored, if and how the cleavage influences FGF10 biological activity during lung 
development. From an evolutionary point of view, the proteolytic regulation of 
protein activity was not preserved for most vertebrate FGFs and was probably 
compensated by gene duplication and subsequent functional divergence of 
vertebrate FGF proteins. However, this mechanism was successfully employed for 
the activation of other signaling molecules in vertebrates (VEGF, PDGF and 
others) (Stacker et al., 1999; Siegfried et al., 2003). However, the experimental 
data described in this thesis suggest that the observed proteolytic processing of 
Drosophila FGF Bnl is preserved in course of evolution and may be involved in 
regulation of FGF10 function during lung development in vertebrates. 
 
4.9 Possible implications of Bnl post-translational regulation in 
Drosophila 
 According to current data, Bnl undergoes proteolytic processing releasing 
its central functional domain, which is required and sufficient for Btl receptor 
activation. Interestingly, Drosophila FGF ligands are the only members of the FGF 
family known up to date that have such long protein sequences. Although it is not 
clear, whether the activities of the other two Drosophila FGFs, Pyr and Ths, are 
regulated by proteolytic cleavage, the data presented here strongly indicate that 
Bnl requires proteolytic processing for its activation. This observation suggests 
that the processing serves as an additional mechanism of FGF activity regulation 
in Drosophila. 
Drosophila Bnl demonstrates a highly dynamic expression pattern during 
embryonic development that relies on complex transcriptional regulation (Merabet 
et al., 2005). Oriented migration of the tracheal cells requires a precise temporal 
pattern of Bnl expression. However, de novo protein synthesis takes time and is 
not helpful in case of the urgent need of the ligand. Therefore, the reported Bnl 
processing may represent a fast reacting mechanism of Bnl activation during 
tracheal morphogenesis. This would imply that Bnl precursors or partially 
processed forms have to be stored in the producing cells until the active ligands 
are needed. In case of demand, the proteins can be immediately activated and 
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quickly exported from the cells. Moreover, partial processing of the precursors 
may contribute to protein stability during the storage. 
Alternatively, proteolytic processing may serve as an additional control of 
ligand quality before the secretion. If the newly synthesized Bnl molecule carries 
non-tolerable amino acid substitutions or folding problems, it will not be 
proteolytically processed and will be secreted as an inactive precursor. However, 
this situation implies that the uncleaved Bnl precursor has to demonstrate the 
impaired extracellular motility and cannot effectively compete with mature Bnl 
ligands for the receptor binding. 
Furthermore, since the Bnl protein contains four potential furin cleavage 
motives, partial proteolytic processing of these sites by Dfur1 may generate Bnl 
isoforms of different length with differential biological activities. Some of 
vertebrate FGF ligands were described to exist as several isoforms with different 
length and subcellular localizations, which expands the diversity of the available 
effector molecules (Acland et al., 1990; Kiefer et al., 1994). Currently, little is 
known about FGF signaling in insects. In contrast to the variety of vertebrate 
FGFs, there are only three FGF homologues in Drosophila melanogaster. They 
were implicated in a limited number of biological functions, mainly during 
embryonic development, and were not shown to have structurally or functionally 
different isoforms (Gryzik et al., 2004; Stathopoulos et al., 2004; Klingseisen et 
al., 2009; Kadam et al., 2009). Based on the vertebrate studies and on the data 
from this work, the phenomenon of proteolytic Bnl processing may represent a 
mechanism for generation of diverse FGF ligands from a single bnl gene. 
According to this assumption, differential proteolytic processing of Bnl furin sites 
may be regulated by different tissue- or cell-specific post-translational 
modification and thus provide differential Bnl function at later stages of tracheal 
development (see Introduction 1.4.2.2). Further study is required to 
experimentally explore all these hypotheses. 
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SUMMARY 
 The present thesis reports about proteolytic processing of a Drosophila 
fibroblast growth factor (FGF) homolog Branchless (Bnl). This secreted protein is 
essential for the development of embryonic and larval tracheal system. Bnl is 
shown to directly interact with a receptor tyrosine kinase Breathless (Btl) that is 
localized on the surface of tracheal cells. Extracellular Bnl functions as a 
chemoattractant for the growing tracheal branches. It directs migration of the 
tracheal cells and provides a stereotyped branching pattern for the newly forming 
respiratory network. Furthermore, Bnl-mediated signaling is required for specific 
upregulation of branch-dependent genes and formation of terminal branches. 
Animals deficient for Bnl activity do not develop a normal tracheal system and 
eventually die during early larval stages. Despite high percent of amino acid 
homology between Bnl and vertebrate FGFs, there is a remarkable difference in 
molecular masses of the insect and vertebrate proteins. Drosophila Bnl is 
approximately three times larger than all known vertebrate FGFs. 
Experiments of this study show that the Bnl protein is initially synthesized 
as a larger precursor and is proteolytically cleaved in secreting cells. This 
processing occurs in the secretory pathway of a cell and liberates the biologically 
active central FGF homology domain of Bnl whose molecular mass is comparable 
with that known for vertebrate FGFs. Based on in silico analysis and cell culture 
experiments, Drosophila Furin1 was identified as a protease required for Bnl 
intracellular cleavage. Four furin recognition motives were identified in the Bnl 
protein. Site-directed mutagenesis of the cleavage sites indicated that only three 
of them are actually utilized for Bnl processing in cell culture. Furthermore, 
combination of cell culture based approach and in vivo analysis showed that 
though an uncleavable variant of the Bnl protein is secreted and specifically 
interacts with the Btl receptor, it is unable to activate downstream signaling 
cascade and induce directional migration of tracheal cells. Moreover, the 
uncleavable Bnl functions as a dominant negative ligand when expressed in the 
target tissue. It was also shown that the Bnl FGF domain alone is sufficient to 
provide valid FGF signaling in vivo. Subsequent genetic experiments revealed the 
functional connection between bnl and dfur1 genes, indicating that the processing 
of endogenous Bnl by Dfur1 is essential for proper tracheal development in 
Drosophila.  
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Furthermore, according to the obtained data, the functional homologue of 
Drosophila Bnl, human FGF10, is proteolytically processed by a furin-related 
protease in Drosophila cells, suggesting that Bnl/FGF10 proteolytic cleavage may 
represent an evolutionary conserved mechanism of the FGF signaling regulation 
during morphogenesis of respiratory system. 
Taken together, the experimental evidence from this study suggests a novel 
post-translational mechanism of FGF activity regulation by the furin protease 
during tracheal system development in Drosophila melanogaster. Moreover, it 
opens the possibility that similar proteolytic regulation of FGF function is 
employed in respiratory system development of higher organisms. 
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